[
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1100001",
    "nando_id": "NANDO:1100001",
    "hum_uri": "https://humandbs.dbcls.jp/hum0069",
    "hum_id": "hum0069",
    "label_ja": "神経筋疾患、ウイルス性疾患におけるRNA発現プロファイル解析",
    "label_en": "RNA expression profiling of neuromuscular diseases and viral diseases",
    "type_study_ja": "NGS(small RNA-seq)",
    "type_study_en": "NGS (small RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1100005",
    "nando_id": "NANDO:1100005",
    "hum_uri": "https://humandbs.dbcls.jp/hum0064",
    "hum_id": "hum0064",
    "label_ja": "高齢者がん治療アルゴリズム開発のためのガイドポスト・データベースの構築と必須情報及びその推定モデル",
    "label_en": "Construction of Geriatric Oncology Database for establishment of the Treatment Algorithm: Clinical Data and Questionnaire Survey Results in JapaneseElderly Cancer Patients Retrospective study",
    "type_study_ja": "【ゲノム・遺伝子解析研究】大腸がん、胃がん、肺がんの臨床情報、多型情報、発現情報、メチル化情報 【後ろ向き研究】大腸がん、胃がん、肺がん、糖尿病・腎障害、循環器疾患、呼吸器疾患症例の臨床情報",
    "type_study_en": "1. Genome & Genetic research genotype, methylation, gene expression, clinical data for colorectal, gastric, or lung cancer patients. 2. Retrospective study clinical data for colorectal cancer, gastric cancer, lung cancer, cardiovascular disorders, respiratory dysfunction, diabetes, or nephropathy patients.",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1100006",
    "nando_id": "NANDO:1100006",
    "hum_uri": "https://humandbs.dbcls.jp/hum0382",
    "hum_id": "hum0382",
    "label_ja": "造血器疾患における遺伝子異常・エピジェネティクス異常の解析",
    "label_en": "Analysis of genetic and epigenetic abnormalities in hematopoietic diseases",
    "type_study_ja": "NGS(WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200002",
    "nando_id": "NANDO:1200002",
    "hum_uri": "https://humandbs.dbcls.jp/hum0014",
    "hum_id": "hum0014",
    "label_ja": "オーダーメイド医療の実現プログラム",
    "label_en": "Bio Bank Japan project",
    "type_study_ja": "162,255名の58臨床検査値のGWAS, 2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル(約20万例)から抽出された11,234名の23遺伝子における全てのエクソン領域のTarget Capture Sequencingn解析より得られた体細胞変異データおよびSNPアレイにより得られた染色体変異データ, 心筋梗塞1,765症例、認知症199症例のWGSデータ, 心筋梗塞1,666症例および 対照健常者3,198名のGWAS, 健常者934名の遺伝子型カウント情報 (JSNPのデータ), 食道がん182症例の遺伝子型カウント情報 (JSNPのデータ), 筋萎縮性側索硬化症92症例の遺伝子型カウント情報 (JSNPのデータ), ２型糖尿病9,817症例および 対照者6,763名のGWAS, ２型糖尿病5,646症例および 対照者19,420名のGWAS, アトピー性皮膚炎患者1,472症例および 対照者7,966名のGWAS, 心房細動患者8,180症例のPhenotypeデータ、Genotypeデータ, 心房細動患者8,180症例および対照者28,612名のGWAS, 158,284名のBMIのGWAS, 開放隅角緑内障3,980症例および 対照者18,815名のGWAS, 初潮年齢データを有する女性67,029名および閉経年齢データを有する女性43,861名のGWAS, ２型糖尿病腎症2,809症例および ２型糖尿病対照5,592症例のGWASメタ解析, ２型糖尿病36,614症例および 対照者155,150名のGWASメタ解析, 日本人集団165,436名における喫煙習慣のGWAS, 159,095名の身長のGWAS, 40疾患のGWAS, 日本人集団165,084名における食習慣のGWAS, 冠動脈疾患のGWAS, BBJ第1コホート137,693名の生存に関するGWAS, 心房細動患者9,826症例および対照者140,446名のGWAS(BBJ) 心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析(BBJ、欧米人、FinnGen), 乳がん7,104症例と対照者23,731名の遺伝性乳がん原因11遺伝子翻訳領域のTarget Capture Sequencingデータ, 遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のTarget Capture Sequencingデータ, 膵がん1,005症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, リンパ腫1,982症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 胃がん10,366症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingデータ, BBJ第1コホート4,880名のmobile element多型頻度情報, BBJ第1コホート1,007名のWGSデータ, 胃がん256症例のWGSデータ, BBJ第1コホートおよび第2コホート26.9万名のSNPアレイデータ, 大腸がん617症例のWGSデータ, 糖尿病2,162症例のWGSデータ(low-depth), 胃がん2,067症例のWGSデータ(low-depth), 35疾患各約190症例における遺伝子型カウント情報 (JSNPのデータ), バイオバンクジャパン7,472名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, バイオバンクジャパン3,256名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, 158,284名のBMIデータ 182,505名のGenotypeデータ, 乳がん10,008症例、胃がん10,576症例、大腸がん13,922症例および心不全6,038症例、脳梗塞10,486症例などを含む計140,597名を対象としたTP53のTarget Capture Sequencingデータ",
    "type_study_en": "GWAS for 58 quantitative traits, target sequencing of 23 genes related to clonal hematopoiesis and SNP array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007, WGS for 1,765 myocardial infarction patients and 199 dementia patients, GWAS for MI, Genotype frequencies in 934 healthy individuals (JSNP data), Genotype frequencies in 182 esophageal cancer patients (JSNP data), Genotype frequencies in 92 amyotrophic lateral sclerosis (ALS) patients (JSNP data), GWAS for T2DM [1], GWAS for T2DM [2], GWAS for AD, Genotype and phenotype data for 8180 AF patients, GWAS for AF, GWAS for BMI, GWAS for POAG, GWAS for age at menarche and menopause, meta analysis of 2 GWASs for T2DM with diabetic nephropathy, meta analysis of 4 GWASs for T2DM, GWAS for smoking behaviour, GWAS for height, GWAS for 40 diseases, GWAS for dietary habits, GWAS for coronary artery disease, GWAS for survival time in 137,693 individuals from BBJ 1st cohort, GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort GWAS meta-analysis for 77,690 AF patients and 1,167,040 controls, target sequencing of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls, target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls, target sequencing of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients, target sequencing of 27 cancer-predisposing genes in 12,503 colorectal cancer patients and 23,705 controls, target sequencing of 27 cancer-predisposing genes in 1,982 lymphoma patients, target sequencing of 27 cancer-predisposing genes in 10,366 gastric cancer patients, target sequencings of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls, mobile element variations in 4,880 individuals from BBJ 1st cohort, WGS for 1,007 individuals, WGS for 256 gastric cancer patients, SNP array for 269,000 patients (51 diseases) in BBJ 1st and 2nd cohort, WGS for 617 colorectal cancer patients, low-depth WGS for 2,162 diabetes patients, low-depth WGS for 2,067 gastric cancer patients, Genotype frequencies in each disease (JSNP data), Imputation reference panel for 7,472 Japanese WGS and 2,504 1000 Genome Project data, Imputation reference panel for 3,256 Japanese WGS and 2,504 1000 Genome Project data, BMI data for 158,284 individuals Genotype data for 182,505 individuals, target sequencings on the coding regions of TP53 in 140,597 individuals, including those with breast cancer, stomach cancer, colon cancer, heart failure, stroke, etc.",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200002",
    "nando_id": "NANDO:1200002",
    "hum_uri": "https://humandbs.dbcls.jp/hum0018",
    "hum_id": "hum0018",
    "label_ja": "神経筋変性疾患の遺伝子解析研究",
    "label_en": "Genetic analysis in neurodegenerative disorders",
    "type_study_ja": "NGS(Exome), NGS(WGS、Exome、RNA-seq), NGS(WGS、Exome)",
    "type_study_en": "NGS (Exome), NGS (WGS, Exome, RNA-seq), NGS (WGS, Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200002",
    "nando_id": "NANDO:1200002",
    "hum_uri": "https://humandbs.dbcls.jp/hum0020",
    "hum_id": "hum0020",
    "label_ja": "筋萎縮性側索硬化症の遺伝子解析研究",
    "label_en": "Genetic Analysis in Amyotrophic Lateral Sclerosis",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200002",
    "nando_id": "NANDO:1200002",
    "hum_uri": "https://humandbs.dbcls.jp/hum0484",
    "hum_id": "hum0484",
    "label_ja": "ヒト体細胞から樹立したInduced Pluripotent Stem Cell Line（iPS細胞株）のバンク事業",
    "label_en": "Banking of induced pluripotent stem cell lines (iPS cell lines) established from human somatic cells",
    "type_study_ja": "NGS(WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200002",
    "nando_id": "NANDO:1200002",
    "hum_uri": "https://humandbs.dbcls.jp/hum0488",
    "hum_id": "hum0488",
    "label_ja": "筋萎縮性側索硬化症におけるTDP-43関連遺伝子発現制御機構の解析",
    "label_en": "Analysis of Mechanisms Regulating TDP-43-Related Gene Expression in Amyotrophic Lateral Sclerosis (ALS)",
    "type_study_ja": "NGS(bulk RNA-seq), NGS(WGS、snRNA-seq、snATAC-seq)",
    "type_study_en": "NGS (bulk RNA-seq), NGS (WGS, snRNA-seq, snATAC-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200010",
    "nando_id": "NANDO:1200010",
    "hum_uri": "https://humandbs.dbcls.jp/hum0113",
    "hum_id": "hum0113",
    "label_ja": "パーキンソン病の代謝産物バイオマーカー創出およびその分子標的機構に基づく創薬シーズ同定",
    "label_en": "Development of metabolite biomarkers of Parkinson’s disease and identification of drug seeds from chemical screening based on the biomarkers",
    "type_study_ja": "NGS(CAGE-seq)",
    "type_study_en": "NGS (CAGE-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200016",
    "nando_id": "NANDO:1200016",
    "hum_uri": "https://humandbs.dbcls.jp/hum0018",
    "hum_id": "hum0018",
    "label_ja": "神経筋変性疾患の遺伝子解析研究",
    "label_en": "Genetic analysis in neurodegenerative disorders",
    "type_study_ja": "NGS(Exome), NGS(WGS、Exome、RNA-seq), NGS(WGS、Exome)",
    "type_study_en": "NGS (Exome), NGS (WGS, Exome, RNA-seq), NGS (WGS, Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200020",
    "nando_id": "NANDO:1200020",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200020",
    "nando_id": "NANDO:1200020",
    "hum_uri": "https://humandbs.dbcls.jp/hum0321",
    "hum_id": "hum0321",
    "label_ja": "胸腺組織を介した免疫系構築の遺伝子制御に関する研究",
    "label_en": "Comprehensive analysis of interaction between human gene expression and environmental metagenomes",
    "type_study_ja": "NGS(scRNA-seq)",
    "type_study_en": "NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200020",
    "nando_id": "NANDO:1200020",
    "hum_uri": "https://humandbs.dbcls.jp/hum0379",
    "hum_id": "hum0379",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(scRNA-seq、scVDJ-seq)",
    "type_study_en": "NGS (scRNA-seq, scVDJ-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200023",
    "nando_id": "NANDO:1200023",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200023",
    "nando_id": "NANDO:1200023",
    "hum_uri": "https://humandbs.dbcls.jp/hum0379",
    "hum_id": "hum0379",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(scRNA-seq、scVDJ-seq)",
    "type_study_en": "NGS (scRNA-seq, scVDJ-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200027",
    "nando_id": "NANDO:1200027",
    "hum_uri": "https://humandbs.dbcls.jp/hum0324",
    "hum_id": "hum0324",
    "label_ja": "脳血管障害及び神経筋難病の遺伝子解析研究",
    "label_en": "Genetic analysis of cerebrovascular diseases and neuromuscular disorders",
    "type_study_ja": "NGS(WGBS)",
    "type_study_en": "NGS (WGBS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200032",
    "nando_id": "NANDO:1200032",
    "hum_uri": "https://humandbs.dbcls.jp/hum0079",
    "hum_id": "hum0079",
    "label_ja": "神経筋変性疾患の遺伝子解析研究",
    "label_en": "Genetic analysis in neurodegeneraive disorders",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200033",
    "nando_id": "NANDO:1200033",
    "hum_uri": "https://humandbs.dbcls.jp/hum0130",
    "hum_id": "hum0130",
    "label_ja": "ＰＯＥＭＳ症候群の骨髄細胞における遺伝子異常の網羅的解析 造血器腫瘍と骨髄ニッチ細胞の遺伝子異常解析による分子病態の解明と新規治療薬開発の基盤構築",
    "label_en": "Comprehensive genetic analyses of bone marrow cells in POEMS syndrome Analyses of molecular mechanisms of hematological malignancies and bone marrow niche",
    "type_study_ja": "NGS(Exome、Target Capture、RNA-seq), NGS(scRNA-seq、bulk RNA-seq)",
    "type_study_en": "NGS (Exome, Target Capture, RNA-seq), NGS (scRNA-seq, bulk RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200034",
    "nando_id": "NANDO:1200034",
    "hum_uri": "https://humandbs.dbcls.jp/hum0018",
    "hum_id": "hum0018",
    "label_ja": "神経筋変性疾患の遺伝子解析研究",
    "label_en": "Genetic analysis in neurodegenerative disorders",
    "type_study_ja": "NGS(Exome), NGS(WGS、Exome、RNA-seq), NGS(WGS、Exome)",
    "type_study_en": "NGS (Exome), NGS (WGS, Exome, RNA-seq), NGS (WGS, Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200044",
    "nando_id": "NANDO:1200044",
    "hum_uri": "https://humandbs.dbcls.jp/hum0001",
    "hum_id": "hum0001",
    "label_ja": "SCA31罹患患者のゲノム解析データ",
    "label_en": "Sequence Data of a SCA31 Patient",
    "type_study_ja": "NGS (WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200052",
    "nando_id": "NANDO:1200052",
    "hum_uri": "https://humandbs.dbcls.jp/hum0018",
    "hum_id": "hum0018",
    "label_ja": "神経筋変性疾患の遺伝子解析研究",
    "label_en": "Genetic analysis in neurodegenerative disorders",
    "type_study_ja": "NGS(Exome), NGS(WGS、Exome、RNA-seq), NGS(WGS、Exome)",
    "type_study_en": "NGS (Exome), NGS (WGS, Exome, RNA-seq), NGS (WGS, Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200157",
    "nando_id": "NANDO:1200157",
    "hum_uri": "https://humandbs.dbcls.jp/hum0221",
    "hum_id": "hum0221",
    "label_ja": "ヒト疾患特異的iPS細胞を用いた遺伝子解析研究",
    "label_en": "Genetic study using human disease-specific iPS cells",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200183",
    "nando_id": "NANDO:1200183",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200183",
    "nando_id": "NANDO:1200183",
    "hum_uri": "https://humandbs.dbcls.jp/hum0351",
    "hum_id": "hum0351",
    "label_ja": "画像検査と RNF213 遺伝子検査の融合による閉塞性血管障害の新評価体系の確立",
    "label_en": "New classification of occlusive cerebrovascular diseases by combining diagnostic imaging and genetic analysis of RNF213",
    "type_study_ja": "メタゲノム",
    "type_study_en": "Metagenome",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200206",
    "nando_id": "NANDO:1200206",
    "hum_uri": "https://humandbs.dbcls.jp/hum0225",
    "hum_id": "hum0225",
    "label_ja": "HTLV-1関連脊髄症（HAM）におけるゲノム異常及びエピゲノム異常の解析",
    "label_en": "Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis",
    "type_study_ja": "NGS(Target Capture), NGS(RNA-seq、ATAC-seq、scMultiome)",
    "type_study_en": "NGS (Target Capture), NGS (RNA-seq, ATAC-seq, scMultiome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200226",
    "nando_id": "NANDO:1200226",
    "hum_uri": "https://humandbs.dbcls.jp/hum0271",
    "hum_id": "hum0271",
    "label_ja": "ハプロ不全により発症する常染色体優性遺伝性疾患における表現型発現の個体差に関する包括的ゲノム解析研究",
    "label_en": "Comprehensive genome analysis related to individual differences in phenotypic expression in autosomal dominant diseases caused by haploinsufficiency",
    "type_study_ja": "NGS(Target Capture、Target RNA-seq)",
    "type_study_en": "NGS (Target Capture, Target RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200228",
    "nando_id": "NANDO:1200228",
    "hum_uri": "https://humandbs.dbcls.jp/hum0266",
    "hum_id": "hum0266",
    "label_ja": "患者検体を用いた自己免疫性皮膚疾患発症機序の解明",
    "label_en": "Elucidation of the pathogenesis of autoimmune dermatosis using patient samples.",
    "type_study_ja": "NGS(scRNA-seq)",
    "type_study_en": "NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200245",
    "nando_id": "NANDO:1200245",
    "hum_uri": "https://humandbs.dbcls.jp/hum0029",
    "hum_id": "hum0029",
    "label_ja": "Stevens-Johnson症候群に対する 遺伝子多型解析",
    "label_en": "Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome",
    "type_study_ja": "SJSのGWAS, SJS/TENのGWAS",
    "type_study_en": "GWAS for SJS, GWAS for SJS/TEN",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200246",
    "nando_id": "NANDO:1200246",
    "hum_uri": "https://humandbs.dbcls.jp/hum0029",
    "hum_id": "hum0029",
    "label_ja": "Stevens-Johnson症候群に対する 遺伝子多型解析",
    "label_en": "Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome",
    "type_study_ja": "SJSのGWAS, SJS/TENのGWAS",
    "type_study_en": "GWAS for SJS, GWAS for SJS/TEN",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200251",
    "nando_id": "NANDO:1200251",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200262",
    "nando_id": "NANDO:1200262",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200265",
    "nando_id": "NANDO:1200265",
    "hum_uri": "https://humandbs.dbcls.jp/hum0393",
    "hum_id": "hum0393",
    "label_ja": "膠原病類縁疾患患者検体を用いた新規バイオマーカーおよび治療標的分子探索に関する研究",
    "label_en": "To explore new biomarkers or therapeutic target molecules using samples with patients with autoimmune diseases",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200272",
    "nando_id": "NANDO:1200272",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200272",
    "nando_id": "NANDO:1200272",
    "hum_uri": "https://humandbs.dbcls.jp/hum0379",
    "hum_id": "hum0379",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(scRNA-seq、scVDJ-seq)",
    "type_study_en": "NGS (scRNA-seq, scVDJ-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200276",
    "nando_id": "NANDO:1200276",
    "hum_uri": "https://humandbs.dbcls.jp/hum0079",
    "hum_id": "hum0079",
    "label_ja": "神経筋変性疾患の遺伝子解析研究",
    "label_en": "Genetic analysis in neurodegeneraive disorders",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200277",
    "nando_id": "NANDO:1200277",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200277",
    "nando_id": "NANDO:1200277",
    "hum_uri": "https://humandbs.dbcls.jp/hum0218",
    "hum_id": "hum0218",
    "label_ja": "全身性強皮症患者の遺伝子発現解析",
    "label_en": "Gene expression analysis in systemic sclerosis",
    "type_study_ja": "NGS(scRNA-seq)",
    "type_study_en": "NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200277",
    "nando_id": "NANDO:1200277",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200278",
    "nando_id": "NANDO:1200278",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200279",
    "nando_id": "NANDO:1200279",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200279",
    "nando_id": "NANDO:1200279",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200279",
    "nando_id": "NANDO:1200279",
    "hum_uri": "https://humandbs.dbcls.jp/hum0492",
    "hum_id": "hum0492",
    "label_ja": "産学連携による免疫炎症性難病の新規医薬品開発を目指した探索研究",
    "label_en": "Exploratory research aimed at developing new drugs for difficult-to-treat immune-inflammatory diseases through industry-academia collaboration",
    "type_study_ja": "NGS(scRNA-seq/TCR/BCRレパトア解析) NGS(Visium Spatial Gene Expression)、病理画像",
    "type_study_en": "NGS (scRNA-seq/TCR/BCR repertoire) NGS (Visium Spatial Gene Expression), Histological image",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200279",
    "nando_id": "NANDO:1200279",
    "hum_uri": "https://humandbs.dbcls.jp/hum0519",
    "hum_id": "hum0519",
    "label_ja": "自己免疫疾患の抗原特異性の詳細解析",
    "label_en": "Detailed analysis of antigen specificity in autoimmune diseases",
    "type_study_ja": "NGS(scRNA-seq/TCRレパトア解析)",
    "type_study_en": "NGS (scRNA-seq/TCR repertoire)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200282",
    "nando_id": "NANDO:1200282",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200284",
    "nando_id": "NANDO:1200284",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200284",
    "nando_id": "NANDO:1200284",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200286",
    "nando_id": "NANDO:1200286",
    "hum_uri": "https://humandbs.dbcls.jp/hum0404",
    "hum_id": "hum0404",
    "label_ja": "循環器疾患のゲノム解析技術、iPS細胞技術、ゲノム編集技術を用いた病態解明ならびに治療法開発研究 循環器疾患患者由来iPS細胞を用いた病態解明ならびに新規医療技術開発研究",
    "label_en": "Elucidation of pathology and therapeutic development using genome analysis, iPS cells, and genome editing for cardiovascular diseases Elucidation of pathology and development of novel medical technology using iPS cells derived from patients with cardiovascular disease",
    "type_study_ja": "NGS(scRNA-seq), NGS(WGS)",
    "type_study_en": "NGS (scRNA-seq), NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200295",
    "nando_id": "NANDO:1200295",
    "hum_uri": "https://humandbs.dbcls.jp/hum0097",
    "hum_id": "hum0097",
    "label_ja": "骨髄不全症候群における血球の質に関する検討",
    "label_en": "Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200295",
    "nando_id": "NANDO:1200295",
    "hum_uri": "https://humandbs.dbcls.jp/hum0434",
    "hum_id": "hum0434",
    "label_ja": "T/NK細胞が関連する各種疾患における遺伝子解析",
    "label_en": "Genetic analyses in patients with T or NK cells-associated disorders",
    "type_study_ja": "NGS(Exome) NGS(Target Capture), NGS(Target Capture)",
    "type_study_en": "NGS (Exome) NGS (Target Capture), NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200296",
    "nando_id": "NANDO:1200296",
    "hum_uri": "https://humandbs.dbcls.jp/hum0097",
    "hum_id": "hum0097",
    "label_ja": "骨髄不全症候群における血球の質に関する検討",
    "label_en": "Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200307",
    "nando_id": "NANDO:1200307",
    "hum_uri": "https://humandbs.dbcls.jp/hum0378",
    "hum_id": "hum0378",
    "label_ja": "溶血性貧血の病態解明を目指した基礎研究",
    "label_en": "Basic research to elucidate the pathogenesis of hemolytic anemia",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200320",
    "nando_id": "NANDO:1200320",
    "hum_uri": "https://humandbs.dbcls.jp/hum0101",
    "hum_id": "hum0101",
    "label_ja": "EBウイルス関連リンパ腫を発症した原発性免疫不全症候群の原因遺伝子探索に関する研究",
    "label_en": "Identification of gene mutations in primary immunodeficiency characterized by EBV-associated B-cell lymphoma",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200334",
    "nando_id": "NANDO:1200334",
    "hum_uri": "https://humandbs.dbcls.jp/hum0368",
    "hum_id": "hum0368",
    "label_ja": "全ゲノム配列決定によるICF症候群の新規原因遺伝子の探索および機能解析",
    "label_en": "Identification and functional analysis of novel causative genes of ICF syndrome by whole genome sequencing",
    "type_study_ja": "NGS(PBAT-seq)",
    "type_study_en": "NGS (PBAT-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200366",
    "nando_id": "NANDO:1200366",
    "hum_uri": "https://humandbs.dbcls.jp/hum0476",
    "hum_id": "hum0476",
    "label_ja": "腎臓構成細胞の生物学的機能理解のための先端的解析技術を用いた観察研究",
    "label_en": "Observational studies using advanced analytical techniques to understand the biological functions of kidney component cells",
    "type_study_ja": "NGS(scRNA-seq) NGS(Visium Spatial Gene Expression)、病理画像",
    "type_study_en": "NGS (scRNA-seq) NGS (Visium Spatial Gene Expression), Histological image",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200439",
    "nando_id": "NANDO:1200439",
    "hum_uri": "https://humandbs.dbcls.jp/hum0076",
    "hum_id": "hum0076",
    "label_ja": "日本人原発性胆汁性肝硬変の発症・進展に関わる遺伝因子の網羅的遺伝子解析",
    "label_en": "Genome-wide search for susceptibility genes to primary biliary chirrosis",
    "type_study_ja": "PBC 487症例および健常対照者476名のGWAS",
    "type_study_en": "GWAS",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200439",
    "nando_id": "NANDO:1200439",
    "hum_uri": "https://humandbs.dbcls.jp/hum0261",
    "hum_id": "hum0261",
    "label_ja": "原発性胆汁性胆管炎の病態解明のためのゲノムワイド関連解析 ― 1,000 症例の追加解析 ―",
    "label_en": "Genome-wide association study of primary biliary cholangitis (PBC) －an additional study of 1,000 Japanese PBC patients－",
    "type_study_ja": "PBC1,953症例および健常対照者3,690名のRHM, PBC1,953症例および健常対照者3,690名のGWAS, PBC1,920症例および健常対照者1,770名のGWAS",
    "type_study_en": "RHM for 1,953 PBCs and 3,690 healthy controls, GWAS for 1,953 PBCs and 3,690 healthy controls, GWAS for 1,920 PBCs and 1,770 healthy controls",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200444",
    "nando_id": "NANDO:1200444",
    "hum_uri": "https://humandbs.dbcls.jp/hum0125",
    "hum_id": "hum0125",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200444",
    "nando_id": "NANDO:1200444",
    "hum_uri": "https://humandbs.dbcls.jp/hum0166",
    "hum_id": "hum0166",
    "label_ja": "炎症性腸疾患患者におけるチオプリン関連副作用とNUDT15遺伝子多型との相関性に関する多施設共同研究（MENDEL Study）",
    "label_en": "Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study)",
    "type_study_ja": "炎症性腸疾患2680症例の個人毎のSNPアレイデータ, 炎症性腸疾患1221症例に対するチオプリン製剤による副作用(白血球減少症、脱毛症)の有無に関するGWAS",
    "type_study_en": "SNP array data of 2680 patients with inflammatory bowel diseases, GWAS for 1221 patients of inflammatory bowel diseases with thiopurine-induced adverse events (leukopenia, alopecia)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200444",
    "nando_id": "NANDO:1200444",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200444",
    "nando_id": "NANDO:1200444",
    "hum_uri": "https://humandbs.dbcls.jp/hum0454",
    "hum_id": "hum0454",
    "label_ja": "免疫異常に着目した炎症性腸疾患の病因解析および治療反応性解析",
    "label_en": "Etiological and therapeutic response analysis of inflammatory bowel disease focusing on immune abnormalities",
    "type_study_ja": "Xenium In Situ Gene Expression",
    "type_study_en": "Xenium In Situ Gene Expression",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200449",
    "nando_id": "NANDO:1200449",
    "hum_uri": "https://humandbs.dbcls.jp/hum0166",
    "hum_id": "hum0166",
    "label_ja": "炎症性腸疾患患者におけるチオプリン関連副作用とNUDT15遺伝子多型との相関性に関する多施設共同研究（MENDEL Study）",
    "label_en": "Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study)",
    "type_study_ja": "炎症性腸疾患2680症例の個人毎のSNPアレイデータ, 炎症性腸疾患1221症例に対するチオプリン製剤による副作用(白血球減少症、脱毛症)の有無に関するGWAS",
    "type_study_en": "SNP array data of 2680 patients with inflammatory bowel diseases, GWAS for 1221 patients of inflammatory bowel diseases with thiopurine-induced adverse events (leukopenia, alopecia)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200449",
    "nando_id": "NANDO:1200449",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200449",
    "nando_id": "NANDO:1200449",
    "hum_uri": "https://humandbs.dbcls.jp/hum0454",
    "hum_id": "hum0454",
    "label_ja": "免疫異常に着目した炎症性腸疾患の病因解析および治療反応性解析",
    "label_en": "Etiological and therapeutic response analysis of inflammatory bowel disease focusing on immune abnormalities",
    "type_study_ja": "Xenium In Situ Gene Expression",
    "type_study_en": "Xenium In Situ Gene Expression",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200464",
    "nando_id": "NANDO:1200464",
    "hum_uri": "https://humandbs.dbcls.jp/hum0129",
    "hum_id": "hum0129",
    "label_ja": "神経疾患患者からのiPS細胞の樹立とそれを用いた疾患解析に関する研究",
    "label_en": "Research for analyzing mechanistic insight into disease progression of neural disease based on iPS cell technology",
    "type_study_ja": "NGS(ChIP-seq)",
    "type_study_en": "NGS (ChIP-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200495",
    "nando_id": "NANDO:1200495",
    "hum_uri": "https://humandbs.dbcls.jp/hum0404",
    "hum_id": "hum0404",
    "label_ja": "循環器疾患のゲノム解析技術、iPS細胞技術、ゲノム編集技術を用いた病態解明ならびに治療法開発研究 循環器疾患患者由来iPS細胞を用いた病態解明ならびに新規医療技術開発研究",
    "label_en": "Elucidation of pathology and therapeutic development using genome analysis, iPS cells, and genome editing for cardiovascular diseases Elucidation of pathology and development of novel medical technology using iPS cells derived from patients with cardiovascular disease",
    "type_study_ja": "NGS(scRNA-seq), NGS(WGS)",
    "type_study_en": "NGS (scRNA-seq), NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200495",
    "nando_id": "NANDO:1200495",
    "hum_uri": "https://humandbs.dbcls.jp/hum0514",
    "hum_id": "hum0514",
    "label_ja": "骨格筋メッセンジャーRNAの発現解析による神経・筋疾患の病態解明",
    "label_en": "Analysis of skeletal muscle messenger RNA expression to elucidate pathophysiology of neuromuscular diseases",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200549",
    "nando_id": "NANDO:1200549",
    "hum_uri": "https://humandbs.dbcls.jp/hum0018",
    "hum_id": "hum0018",
    "label_ja": "神経筋変性疾患の遺伝子解析研究",
    "label_en": "Genetic analysis in neurodegenerative disorders",
    "type_study_ja": "NGS(Exome), NGS(WGS、Exome、RNA-seq), NGS(WGS、Exome)",
    "type_study_en": "NGS (Exome), NGS (WGS, Exome, RNA-seq), NGS (WGS, Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200552",
    "nando_id": "NANDO:1200552",
    "hum_uri": "https://humandbs.dbcls.jp/hum0347",
    "hum_id": "hum0347",
    "label_ja": "急性脳症の包括的遺伝子解析",
    "label_en": "Comprehensive genetic analysis of acute encephalopathy",
    "type_study_ja": "AESD症例のrs16944(IL1B)のgenotype, AESD症例のGWAS統計情報",
    "type_study_en": "rs16944 genotype of AESD patients, GWAS for AESD",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200607",
    "nando_id": "NANDO:1200607",
    "hum_uri": "https://humandbs.dbcls.jp/hum0375",
    "hum_id": "hum0375",
    "label_ja": "超高速DNAシーケンサーを用いた疾患原因ゲノム領域の同定と情報解析法の確立、および参照配列データの作成に関する研究",
    "label_en": "identification of disease responsible genome region and establishment of genome information technology by next generation DNA sequencer",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200633",
    "nando_id": "NANDO:1200633",
    "hum_uri": "https://humandbs.dbcls.jp/hum0163",
    "hum_id": "hum0163",
    "label_ja": "精神・神経疾患治療薬及びがん治療薬におけるファーマコゲノミクス研究",
    "label_en": "Pharmacogenomics research for therapeutics in psychiatry, neurology and oncology",
    "type_study_ja": "NGS(Target Capture), NGS(NAT2ハプロタイプ同定), 水疱性類天疱瘡のGWAS",
    "type_study_en": "NGS (Target Capture), NGS (NAT2 haplotype), GWAS for bullous pemphigoid",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200655",
    "nando_id": "NANDO:1200655",
    "hum_uri": "https://humandbs.dbcls.jp/hum0302",
    "hum_id": "hum0302",
    "label_ja": "iPS細胞の高次特性解析と加工iPS細胞の作製",
    "label_en": "iPS Cell Advanced Characterization and Development of modified iPS cells",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200664",
    "nando_id": "NANDO:1200664",
    "hum_uri": "https://humandbs.dbcls.jp/hum0131",
    "hum_id": "hum0131",
    "label_ja": "発達障害のエピゲノム解析",
    "label_en": "The epigenetics of neurodevelopmental disorders",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200719",
    "nando_id": "NANDO:1200719",
    "hum_uri": "https://humandbs.dbcls.jp/hum0126",
    "hum_id": "hum0126",
    "label_ja": "小児ネフローゼ症候群の疾患感受性遺伝子及び薬剤感受性遺伝子同定研究",
    "label_en": "Identification of the disease and drug susceptibility genes for the Childhood Idiopathic Nephrotic Syndrome",
    "type_study_ja": "小児ネフローゼ症候群224症例および対照419名のGWAS, 小児ネフローゼ症候群987症例および対照3,206名のGWAS",
    "type_study_en": "GWAS for 224 Childhood Idiopathic Nephrotic Syndrome patients and 419 healthy adult controls, GWAS for 3,206 Childhood Idiopathic Nephrotic Syndrome patients and 987 healthy adult controls",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200747",
    "nando_id": "NANDO:1200747",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200889",
    "nando_id": "NANDO:1200889",
    "hum_uri": "https://humandbs.dbcls.jp/hum0434",
    "hum_id": "hum0434",
    "label_ja": "T/NK細胞が関連する各種疾患における遺伝子解析",
    "label_en": "Genetic analyses in patients with T or NK cells-associated disorders",
    "type_study_ja": "NGS(Exome) NGS(Target Capture), NGS(Target Capture)",
    "type_study_en": "NGS (Exome) NGS (Target Capture), NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200903",
    "nando_id": "NANDO:1200903",
    "hum_uri": "https://humandbs.dbcls.jp/hum0008",
    "hum_id": "hum0008",
    "label_ja": "ヒルシュスプルング病および ヒルシュスプルング類縁疾患の 遺伝要因および発症機構解明に関する研究",
    "label_en": "Research for genetic causes and mechanisms of Hirschsprung's",
    "type_study_ja": "NGS (Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200913",
    "nando_id": "NANDO:1200913",
    "hum_uri": "https://humandbs.dbcls.jp/hum0486",
    "hum_id": "hum0486",
    "label_ja": "胆道閉鎖症およびアラジール症候群特異的iPS細胞を用いた胆管発生およびその障害メカニズムの解明",
    "label_en": "Bile duct development and its failure mechanisms using biliary atresia and Alagille syndrome-specific iPS cells",
    "type_study_ja": "NGS(WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1200941",
    "nando_id": "NANDO:1200941",
    "hum_uri": "https://humandbs.dbcls.jp/hum0005",
    "hum_id": "hum0005",
    "label_ja": "難聴の遺伝子解析と臨床応用に関する研究",
    "label_en": "Genetic Analysis of Hearing Loss and Its Clinical Application",
    "type_study_ja": "NGS (Target Capture), NGS (Target Capture) 69遺伝子領域・90遺伝子領域, NGS (Target Capture) 69遺伝子領域・63遺伝子領域・90遺伝子領域, NGS (Target Capture) 69遺伝子領域・63遺伝子領域",
    "type_study_en": "NGS (Target Capture: Nine genes), NGS (Target Capture), NGS (Target Capture) 69 genes・90 genes, NGS (Target Capture) 69 genes・63 genes・90 genes, NGS (Target Capture) 69 genes・63 genes",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1201001",
    "nando_id": "NANDO:1201001",
    "hum_uri": "https://humandbs.dbcls.jp/hum0508",
    "hum_id": "hum0508",
    "label_ja": "疾患特異的iPS細胞を用いた眼疾患の発症機序の解明および治療法の探索",
    "label_en": "Elucidation of the pathogenesis of ocular diseases and exploration of therapeutic strategies using disease-specific iPS cells",
    "type_study_ja": "NGS(scRNA-seq)",
    "type_study_en": "NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_1201096",
    "nando_id": "NANDO:1201096",
    "hum_uri": "https://humandbs.dbcls.jp/hum0406",
    "hum_id": "hum0406",
    "label_ja": "ヒト疾患特異的iPS細胞の作成とそれを用いた疾患解析に関する研究",
    "label_en": "The Generation of Human Disease-Specific iPS Cells and the Use of Such iPS Cells for Disease Analysis",
    "type_study_ja": "NGS(RNA-seq), NGS(scRNA-seq)",
    "type_study_en": "NGS (RNA-seq), NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2100002",
    "nando_id": "NANDO:2100002",
    "hum_uri": "https://humandbs.dbcls.jp/hum0022",
    "hum_id": "hum0022",
    "label_ja": "同種造血幹細胞移植後 ドナー由来白血病発症にかかわる 分子機構の解析",
    "label_en": "Analysis of the Molecular Mechanism for Developing Donor-Origin Leukemia after Allogeneic Stem Cell Transplantation.",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2100004",
    "nando_id": "NANDO:2100004",
    "hum_uri": "https://humandbs.dbcls.jp/hum0014",
    "hum_id": "hum0014",
    "label_ja": "オーダーメイド医療の実現プログラム",
    "label_en": "Bio Bank Japan project",
    "type_study_ja": "162,255名の58臨床検査値のGWAS, 2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル(約20万例)から抽出された11,234名の23遺伝子における全てのエクソン領域のTarget Capture Sequencingn解析より得られた体細胞変異データおよびSNPアレイにより得られた染色体変異データ, 心筋梗塞1,765症例、認知症199症例のWGSデータ, 心筋梗塞1,666症例および 対照健常者3,198名のGWAS, 健常者934名の遺伝子型カウント情報 (JSNPのデータ), 食道がん182症例の遺伝子型カウント情報 (JSNPのデータ), 筋萎縮性側索硬化症92症例の遺伝子型カウント情報 (JSNPのデータ), ２型糖尿病9,817症例および 対照者6,763名のGWAS, ２型糖尿病5,646症例および 対照者19,420名のGWAS, アトピー性皮膚炎患者1,472症例および 対照者7,966名のGWAS, 心房細動患者8,180症例のPhenotypeデータ、Genotypeデータ, 心房細動患者8,180症例および対照者28,612名のGWAS, 158,284名のBMIのGWAS, 開放隅角緑内障3,980症例および 対照者18,815名のGWAS, 初潮年齢データを有する女性67,029名および閉経年齢データを有する女性43,861名のGWAS, ２型糖尿病腎症2,809症例および ２型糖尿病対照5,592症例のGWASメタ解析, ２型糖尿病36,614症例および 対照者155,150名のGWASメタ解析, 日本人集団165,436名における喫煙習慣のGWAS, 159,095名の身長のGWAS, 40疾患のGWAS, 日本人集団165,084名における食習慣のGWAS, 冠動脈疾患のGWAS, BBJ第1コホート137,693名の生存に関するGWAS, 心房細動患者9,826症例および対照者140,446名のGWAS(BBJ) 心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析(BBJ、欧米人、FinnGen), 乳がん7,104症例と対照者23,731名の遺伝性乳がん原因11遺伝子翻訳領域のTarget Capture Sequencingデータ, 遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のTarget Capture Sequencingデータ, 膵がん1,005症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, リンパ腫1,982症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 胃がん10,366症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingデータ, BBJ第1コホート4,880名のmobile element多型頻度情報, BBJ第1コホート1,007名のWGSデータ, 胃がん256症例のWGSデータ, BBJ第1コホートおよび第2コホート26.9万名のSNPアレイデータ, 大腸がん617症例のWGSデータ, 糖尿病2,162症例のWGSデータ(low-depth), 胃がん2,067症例のWGSデータ(low-depth), 35疾患各約190症例における遺伝子型カウント情報 (JSNPのデータ), バイオバンクジャパン7,472名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, バイオバンクジャパン3,256名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, 158,284名のBMIデータ 182,505名のGenotypeデータ, 乳がん10,008症例、胃がん10,576症例、大腸がん13,922症例および心不全6,038症例、脳梗塞10,486症例などを含む計140,597名を対象としたTP53のTarget Capture Sequencingデータ",
    "type_study_en": "GWAS for 58 quantitative traits, target sequencing of 23 genes related to clonal hematopoiesis and SNP array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007, WGS for 1,765 myocardial infarction patients and 199 dementia patients, GWAS for MI, Genotype frequencies in 934 healthy individuals (JSNP data), Genotype frequencies in 182 esophageal cancer patients (JSNP data), Genotype frequencies in 92 amyotrophic lateral sclerosis (ALS) patients (JSNP data), GWAS for T2DM [1], GWAS for T2DM [2], GWAS for AD, Genotype and phenotype data for 8180 AF patients, GWAS for AF, GWAS for BMI, GWAS for POAG, GWAS for age at menarche and menopause, meta analysis of 2 GWASs for T2DM with diabetic nephropathy, meta analysis of 4 GWASs for T2DM, GWAS for smoking behaviour, GWAS for height, GWAS for 40 diseases, GWAS for dietary habits, GWAS for coronary artery disease, GWAS for survival time in 137,693 individuals from BBJ 1st cohort, GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort GWAS meta-analysis for 77,690 AF patients and 1,167,040 controls, target sequencing of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls, target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls, target sequencing of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients, target sequencing of 27 cancer-predisposing genes in 12,503 colorectal cancer patients and 23,705 controls, target sequencing of 27 cancer-predisposing genes in 1,982 lymphoma patients, target sequencing of 27 cancer-predisposing genes in 10,366 gastric cancer patients, target sequencings of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls, mobile element variations in 4,880 individuals from BBJ 1st cohort, WGS for 1,007 individuals, WGS for 256 gastric cancer patients, SNP array for 269,000 patients (51 diseases) in BBJ 1st and 2nd cohort, WGS for 617 colorectal cancer patients, low-depth WGS for 2,162 diabetes patients, low-depth WGS for 2,067 gastric cancer patients, Genotype frequencies in each disease (JSNP data), Imputation reference panel for 7,472 Japanese WGS and 2,504 1000 Genome Project data, Imputation reference panel for 3,256 Japanese WGS and 2,504 1000 Genome Project data, BMI data for 158,284 individuals Genotype data for 182,505 individuals, target sequencings on the coding regions of TP53 in 140,597 individuals, including those with breast cancer, stomach cancer, colon cancer, heart failure, stroke, etc.",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2100004",
    "nando_id": "NANDO:2100004",
    "hum_uri": "https://humandbs.dbcls.jp/hum0130",
    "hum_id": "hum0130",
    "label_ja": "ＰＯＥＭＳ症候群の骨髄細胞における遺伝子異常の網羅的解析 造血器腫瘍と骨髄ニッチ細胞の遺伝子異常解析による分子病態の解明と新規治療薬開発の基盤構築",
    "label_en": "Comprehensive genetic analyses of bone marrow cells in POEMS syndrome Analyses of molecular mechanisms of hematological malignancies and bone marrow niche",
    "type_study_ja": "NGS(Exome、Target Capture、RNA-seq), NGS(scRNA-seq、bulk RNA-seq)",
    "type_study_en": "NGS (Exome, Target Capture, RNA-seq), NGS (scRNA-seq, bulk RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2100175",
    "nando_id": "NANDO:2100175",
    "hum_uri": "https://humandbs.dbcls.jp/hum0382",
    "hum_id": "hum0382",
    "label_ja": "造血器疾患における遺伝子異常・エピジェネティクス異常の解析",
    "label_en": "Analysis of genetic and epigenetic abnormalities in hematopoietic diseases",
    "type_study_ja": "NGS(WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2100214",
    "nando_id": "NANDO:2100214",
    "hum_uri": "https://humandbs.dbcls.jp/hum0069",
    "hum_id": "hum0069",
    "label_ja": "神経筋疾患、ウイルス性疾患におけるRNA発現プロファイル解析",
    "label_en": "RNA expression profiling of neuromuscular diseases and viral diseases",
    "type_study_ja": "NGS(small RNA-seq)",
    "type_study_en": "NGS (small RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2100250",
    "nando_id": "NANDO:2100250",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2100259",
    "nando_id": "NANDO:2100259",
    "hum_uri": "https://humandbs.dbcls.jp/hum0166",
    "hum_id": "hum0166",
    "label_ja": "炎症性腸疾患患者におけるチオプリン関連副作用とNUDT15遺伝子多型との相関性に関する多施設共同研究（MENDEL Study）",
    "label_en": "Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study)",
    "type_study_ja": "炎症性腸疾患2680症例の個人毎のSNPアレイデータ, 炎症性腸疾患1221症例に対するチオプリン製剤による副作用(白血球減少症、脱毛症)の有無に関するGWAS",
    "type_study_en": "SNP array data of 2680 patients with inflammatory bowel diseases, GWAS for 1221 patients of inflammatory bowel diseases with thiopurine-induced adverse events (leukopenia, alopecia)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200001",
    "nando_id": "NANDO:2200001",
    "hum_uri": "https://humandbs.dbcls.jp/hum0251",
    "hum_id": "hum0251",
    "label_ja": "成人フィラデルフィア染色体陰性precursor B細胞性急性リンパ性白血病に対する多剤併用化学療法による第Ⅱ相臨床試験",
    "label_en": "Phase II clinical trial of adult Philadelphia chromosome-negative precursor B-cell acute lymphocytic leukemia with combination chemotherapy",
    "type_study_ja": "NGS(RNA-seq、Target Capture)",
    "type_study_en": "NGS (RNA-seq, Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200001",
    "nando_id": "NANDO:2200001",
    "hum_uri": "https://humandbs.dbcls.jp/hum0318",
    "hum_id": "hum0318",
    "label_ja": "血液疾患のゲノム解析研究",
    "label_en": "Clinical sequence of hematological malignancy",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200001",
    "nando_id": "NANDO:2200001",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200003",
    "nando_id": "NANDO:2200003",
    "hum_uri": "https://humandbs.dbcls.jp/hum0096",
    "hum_id": "hum0096",
    "label_ja": "造血器腫瘍における遺伝子異常の網羅的解析（小児T細胞性急性リンパ性白血病）",
    "label_en": "Comprehensive analysis of genetic alterations in hematological malignancies",
    "type_study_ja": "NGS(RNA-seq), メチル化アレイ",
    "type_study_en": "NGS (RNA-seq), Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200004",
    "nando_id": "NANDO:2200004",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200004",
    "nando_id": "NANDO:2200004",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200005",
    "nando_id": "NANDO:2200005",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200005",
    "nando_id": "NANDO:2200005",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200006",
    "nando_id": "NANDO:2200006",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200006",
    "nando_id": "NANDO:2200006",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200007",
    "nando_id": "NANDO:2200007",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200007",
    "nando_id": "NANDO:2200007",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200008",
    "nando_id": "NANDO:2200008",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200008",
    "nando_id": "NANDO:2200008",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200009",
    "nando_id": "NANDO:2200009",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200009",
    "nando_id": "NANDO:2200009",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200010",
    "nando_id": "NANDO:2200010",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200010",
    "nando_id": "NANDO:2200010",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200011",
    "nando_id": "NANDO:2200011",
    "hum_uri": "https://humandbs.dbcls.jp/hum0116",
    "hum_id": "hum0116",
    "label_ja": "ヒト化マウス（humanized mouse) の作製と免疫学研究への応用",
    "label_en": "Development of hunanized mice for human immunity research",
    "type_study_ja": "NGS(Target Capture): AML Cancer Panel NGS(Target Capture): 41遺伝子, NGS(single cell RNA-seq)",
    "type_study_en": "NGS (Target Capture): AML cancer panel NGS (Target Capture): 41 genes, NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200011",
    "nando_id": "NANDO:2200011",
    "hum_uri": "https://humandbs.dbcls.jp/hum0405",
    "hum_id": "hum0405",
    "label_ja": "小児・成人悪性腫瘍がん幹細胞の同定に関する研究",
    "label_en": "Research on the identification of cancer stem cells for peidatric and adult malignancies",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS、Exome、Amplicon-seq、RNA-seq、scRNA-seq/ADT-seq/TCR-seq、CUT&RUN-seq) メチル化アレイ",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (RNA-seq), NGS (Exome) NGS (RNA-seq) NGS (small RNA-seq), NGS (WGS, Exome, Amplicon-seq, RNA-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200014",
    "nando_id": "NANDO:2200014",
    "hum_uri": "https://humandbs.dbcls.jp/hum0024",
    "hum_id": "hum0024",
    "label_ja": "造血器腫瘍における 遺伝子異常の網羅的解析",
    "label_en": "Comprehensive Analysis of Genetic Alterations in Hematological Malignancies",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200014",
    "nando_id": "NANDO:2200014",
    "hum_uri": "https://humandbs.dbcls.jp/hum0289",
    "hum_id": "hum0289",
    "label_ja": "慢性骨髄単球性白血病（CMML）における同種移植後再発メカニズムの探索",
    "label_en": "Mechanisms on relapse after allogeneic hematopoietic cell transplantation in CMML",
    "type_study_ja": "NGS(RNA-seq) NGS(Exome) メチル化アレイ",
    "type_study_en": "NGS (RNA-seq) NGS (Exome) Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200015",
    "nando_id": "NANDO:2200015",
    "hum_uri": "https://humandbs.dbcls.jp/hum0024",
    "hum_id": "hum0024",
    "label_ja": "造血器腫瘍における 遺伝子異常の網羅的解析",
    "label_en": "Comprehensive Analysis of Genetic Alterations in Hematological Malignancies",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200015",
    "nando_id": "NANDO:2200015",
    "hum_uri": "https://humandbs.dbcls.jp/hum0263",
    "hum_id": "hum0263",
    "label_ja": "若年性骨髄単球性白血病における遺伝子異常の網羅的解析",
    "label_en": "Comprehensive analysis of the abnormality of the genes in juvenile myelomonocytic leukemia",
    "type_study_ja": "NGS(DREAM-seq)",
    "type_study_en": "NGS (DREAM-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200018",
    "nando_id": "NANDO:2200018",
    "hum_uri": "https://humandbs.dbcls.jp/hum0465",
    "hum_id": "hum0465",
    "label_ja": "混合形質性急性白血病細胞株の樹立とゲノム解析",
    "label_en": "Establishment and genomic analysis of mixed phenotypic acute leukemia cell lines",
    "type_study_ja": "NGS(Exome、RNA-seq)",
    "type_study_en": "NGS (Exome, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200019",
    "nando_id": "NANDO:2200019",
    "hum_uri": "https://humandbs.dbcls.jp/hum0024",
    "hum_id": "hum0024",
    "label_ja": "造血器腫瘍における 遺伝子異常の網羅的解析",
    "label_en": "Comprehensive Analysis of Genetic Alterations in Hematological Malignancies",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200019",
    "nando_id": "NANDO:2200019",
    "hum_uri": "https://humandbs.dbcls.jp/hum0165",
    "hum_id": "hum0165",
    "label_ja": "家族性骨髄異形成症候群の遺伝子解析研究",
    "label_en": "Genetic analysis of familial myelodysplastic syndromes",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200019",
    "nando_id": "NANDO:2200019",
    "hum_uri": "https://humandbs.dbcls.jp/hum0384",
    "hum_id": "hum0384",
    "label_ja": "造血器腫瘍の分子病態の解明と新規治療薬開発の基盤構築",
    "label_en": "Deciphering molecular mechanisms underlying hematological malignancies and development of novel therapeutic approaches",
    "type_study_ja": "NGS(RNA-seq、Target Capture), NGS(RNA-seq、ATAC-seq)",
    "type_study_en": "NGS (RNA-seq, Target Capture), NGS (RNA-seq, ATAC-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200019",
    "nando_id": "NANDO:2200019",
    "hum_uri": "https://humandbs.dbcls.jp/hum0473",
    "hum_id": "hum0473",
    "label_ja": "造血器腫瘍患者の遺伝子解析による発症機序解明研究 血縁ドナーの微量残存骨髄液を正常コントロールとした造血器腫瘍特異的分子発現解析",
    "label_en": "Elucidation of the pathogenesis of hematopoietic neoplasms via genetic analysis Molecular expression analysis of bone marrow cells from hematopoietic stem cell transplant donors as a normal control",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200020",
    "nando_id": "NANDO:2200020",
    "hum_uri": "https://humandbs.dbcls.jp/hum0134",
    "hum_id": "hum0134",
    "label_ja": "Bリンパ腫の転移/再発に特徴的な遺伝子変異の同定",
    "label_en": "Identification of genetic mutations characteristic for recurrence and metastasis of B cell lymphoma.",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200031",
    "nando_id": "NANDO:2200031",
    "hum_uri": "https://humandbs.dbcls.jp/hum0367",
    "hum_id": "hum0367",
    "label_ja": "血液疾患のゲノム解析研究",
    "label_en": "Clinical sequence of hematological malignancy",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200040",
    "nando_id": "NANDO:2200040",
    "hum_uri": "https://humandbs.dbcls.jp/hum0035",
    "hum_id": "hum0035",
    "label_ja": "固形腫瘍における遺伝子異常の網羅的解析",
    "label_en": "Genome wide analysis of gene mutations in solid tumors",
    "type_study_ja": "RMSおよびPPBのNGS(Exome), PBLのSNP-chip PBLのメチル化アレイ PBLのNGS(Exome) PBLのNGS(RNA-seq), NBのSNP-chip NBのTarget amplicon deep sequencing(NGS), HBLのSNP-chip HBLのメチル化アレイ HBLのNGS(Target Capture) HBLのNGS(RNA-seq), 小児胚細胞腫瘍のSNP-chip 小児胚細胞腫瘍のメチル化アレイ 小児胚細胞腫瘍のNGS(Target Capture) 小児胚細胞腫瘍のNGS(RNA-seq), 小児高リスク神経芽腫のNGS(RNA-seq) 小児高リスク神経芽腫のNGS(Target Capture)",
    "type_study_en": "NGS (Exome) for RMS and PPB, SNP-chip for PBL Methylation array for PBL NGS (Exome) for PBL NGS (RNA-seq) for PBL, SNP-chip for NB Target amplicon deep sequencing (NGS) for NB, SNP-chip for HBL Methylation array for HBL NGS (Target Capture) for HBL NGS (RNA-seq) for HBL, SNP-chip for pediatric germ cell tumors Methylation array for pediatric germ cell tumors NGS (Target Capture) for pediatric germ cell tumors NGS (RNA-seq) for pediatric germ cell tumors, NGS (RNA-seq) for high-risk neuroblastoma NGS (Target Capture) for high-risk neuroblastoma",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200042",
    "nando_id": "NANDO:2200042",
    "hum_uri": "https://humandbs.dbcls.jp/hum0340",
    "hum_id": "hum0340",
    "label_ja": "小児固形腫瘍症例の次世代シークエンサーを用いた網羅的ゲノム解析",
    "label_en": "Comprehensive genomic analysis using next-generation sequencer for pediatric solid tumor cases",
    "type_study_ja": "NGS (WGS、Target Capture)",
    "type_study_en": "NGS(WGS, Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200045",
    "nando_id": "NANDO:2200045",
    "hum_uri": "https://humandbs.dbcls.jp/hum0148",
    "hum_id": "hum0148",
    "label_ja": "泌尿器科腫瘍組織での遺伝子異常と発現解析",
    "label_en": "Analysis of abnomal character and expression of genes in tissues of urologic carcinomas.",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200045",
    "nando_id": "NANDO:2200045",
    "hum_uri": "https://humandbs.dbcls.jp/hum0277",
    "hum_id": "hum0277",
    "label_ja": "泌尿器科領域の腫瘍性疾患の発症、進展、及び薬剤の治療効果に関わる遺伝子の解析",
    "label_en": "Analysis of genes related to the oncogenesis, progression or effectiveness of drug therapies of urological tumors",
    "type_study_ja": "NGS(scRNA-seq、Exome、RNA-seq), NGS(WGS、RNA-seq)",
    "type_study_en": "NGS (scRNA-seq, Exome, RNA-seq), NGS (WGS, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200045",
    "nando_id": "NANDO:2200045",
    "hum_uri": "https://humandbs.dbcls.jp/hum0575",
    "hum_id": "hum0575",
    "label_ja": "腎癌における網羅的な遺伝子探索研究",
    "label_en": "Comprehensive gene expression analysis in renal cell carcinoma",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200046",
    "nando_id": "NANDO:2200046",
    "hum_uri": "https://humandbs.dbcls.jp/hum0035",
    "hum_id": "hum0035",
    "label_ja": "固形腫瘍における遺伝子異常の網羅的解析",
    "label_en": "Genome wide analysis of gene mutations in solid tumors",
    "type_study_ja": "RMSおよびPPBのNGS(Exome), PBLのSNP-chip PBLのメチル化アレイ PBLのNGS(Exome) PBLのNGS(RNA-seq), NBのSNP-chip NBのTarget amplicon deep sequencing(NGS), HBLのSNP-chip HBLのメチル化アレイ HBLのNGS(Target Capture) HBLのNGS(RNA-seq), 小児胚細胞腫瘍のSNP-chip 小児胚細胞腫瘍のメチル化アレイ 小児胚細胞腫瘍のNGS(Target Capture) 小児胚細胞腫瘍のNGS(RNA-seq), 小児高リスク神経芽腫のNGS(RNA-seq) 小児高リスク神経芽腫のNGS(Target Capture)",
    "type_study_en": "NGS (Exome) for RMS and PPB, SNP-chip for PBL Methylation array for PBL NGS (Exome) for PBL NGS (RNA-seq) for PBL, SNP-chip for NB Target amplicon deep sequencing (NGS) for NB, SNP-chip for HBL Methylation array for HBL NGS (Target Capture) for HBL NGS (RNA-seq) for HBL, SNP-chip for pediatric germ cell tumors Methylation array for pediatric germ cell tumors NGS (Target Capture) for pediatric germ cell tumors NGS (RNA-seq) for pediatric germ cell tumors, NGS (RNA-seq) for high-risk neuroblastoma NGS (Target Capture) for high-risk neuroblastoma",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200046",
    "nando_id": "NANDO:2200046",
    "hum_uri": "https://humandbs.dbcls.jp/hum0161",
    "hum_id": "hum0161",
    "label_ja": "シークエンス解析によるがんゲノム研究：肝芽腫",
    "label_en": "Genome sequencing analysis for hepatoblastoma",
    "type_study_ja": "NGS(WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200046",
    "nando_id": "NANDO:2200046",
    "hum_uri": "https://humandbs.dbcls.jp/hum0233",
    "hum_id": "hum0233",
    "label_ja": "小児肝癌に対する国際共同臨床試験（PHITT, JPLT4）付随研究",
    "label_en": "Paediatric Hepatic International Tumour Trial (JPLT4: PHITT)",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq) SNPアレイ メチル化アレイ NGS(WGBS)",
    "type_study_en": "NGS (Exome) NGS (RNA-seq) SNP array Methylation array NGS (WGBS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0041",
    "hum_id": "hum0041",
    "label_ja": "肝胆膵癌の早期発見、進行、予後予測、 治療効果予測に関わる因子の研究",
    "label_en": "Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies",
    "type_study_ja": "NGS(Exome、Target Capture)",
    "type_study_en": "NGS (Exome, Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0074",
    "hum_id": "hum0074",
    "label_ja": "テーラーメイド治療を目指した肝炎ウイルスデータベース構築に関する研究",
    "label_en": "Genome-wide association studies on Hepatitis C virus-related diseases and construction of genome database",
    "type_study_ja": "NVR 78症例、SVR 51症例、VR 64症例のGWAS, C型肝炎PEG-IFN/RBV併用療法による 血小板減少＋ 94症例および 血小板減少－ 196症例のGWAS, 進展に伴うヘモグロビン減少＋ 94症例および ヘモグロビン減少－ 209症例のGWAS, SVR後肝がん発症 123症例および 肝がんを発症していない 333症例のGWAS",
    "type_study_en": "GWAS for 78 NVR and 64 VR GWAS for 78 NVR and 51 SVR, GWAS for 107 HCV patients with decrease of PLT in response to PEG-IFN/RBV treatment and 196 HCV patients without decrease of PLT in response to PEG-IFN/RBV treatment, GWAS for 94 HCV patients with Hb reduction and 209 HCV patients without Hb reduction, GWAS for HCC development after eradication of HCV by IFN-based treatment 123 patients who developed HCC 333 patients who did not develop HCC",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0075",
    "hum_id": "hum0075",
    "label_ja": "B型肝炎ウイルス感染の病態別における宿主遺伝因子の探索研究",
    "label_en": "Search for susceptibility genes to hepatitis virus B-related diseases",
    "type_study_ja": "B型肝炎ウイルスキャリア 181症例、および、 健常対照者 184名のGWAS, B型肝炎ウイルスキャリア 181症例、および、 B型肝炎ウイルス排除群 185症例のGWAS, B型肝炎ウイルス排除群 185症例、および、 健常対照者 184名のGWAS, B型ウイルス陽性肝がん 473症例、および、 B型肝炎ウイルスキャリア群 516症例のGWAS, タイ人B型肝炎 329症例、および、 タイ人健常対照者 318名のGWAS",
    "type_study_en": "GWAS for 181 HBV carriers and 184 controls, GWAS for 181 HBV carriers and 185 spontaneously HBV-resolved individuals, GWAS for 185 spontaneously HBV-resolved individuals and 184 controls, GWAS for 473 HBV-positive HCC patients and 516 HBV carriers, GWAS for 329 patients with chronic HBV infection and 318 healthy controls",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0119",
    "hum_id": "hum0119",
    "label_ja": "NASHの発症、進展を規定するメカニズム解析",
    "label_en": "Analysis for mechanism of onset and progress for NASH",
    "type_study_ja": "NAFLD264症例および対照7672名のGWAS NASH580症例および対照7672名のGWAS NASH-HCC58症例および対照7672名のGWAS",
    "type_study_en": "GWAS for NAFLD, NASH, and NASH-HCC",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0138",
    "hum_id": "hum0138",
    "label_ja": "固形腫瘍における遺伝子異常の網羅的解析",
    "label_en": "Clonal structure and oncogenic potential of liver cirrhosis tissues",
    "type_study_ja": "NGS(Exome、RNA-seq)",
    "type_study_en": "NGS (Exome, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0158",
    "hum_id": "hum0158",
    "label_ja": "シークエンス解析によるがんゲノム研究：肝臓がん",
    "label_en": "Genome sequencing analysis for liver cancer",
    "type_study_ja": "NGS(WGS) NGS(RNA-seq)",
    "type_study_en": "NGS (WGS) NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0182",
    "hum_id": "hum0182",
    "label_ja": "全ゲノムシークエンスデータの解析による変異と遺伝的多様性の包括的解析",
    "label_en": "Comprehansive analysis of somatic mutations and genetic variations with whole genome sequencing",
    "type_study_ja": "NGS(WGS): RK067, NGS(WGS): NA18943, NGS(RNA-seq)",
    "type_study_en": "NGS (WGS): RK067, NGS (WGS): NA18943, NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0187",
    "hum_id": "hum0187",
    "label_ja": "消化器癌のゲノム・遺伝子解析とその臨床病理学的意義の解明",
    "label_en": "Genomic and genetic analysis of digestive tract cancer and elucidation of its clinicopathological significance.",
    "type_study_ja": "NGS(Target Capture), NGS(Exome、RNA-seq)、Methylation array",
    "type_study_en": "NGS (Target Capture), NGS (Exome, RNA-seq), Methylation array",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0195",
    "hum_id": "hum0195",
    "label_ja": "消化器癌における遺伝子異常についての網羅的解析",
    "label_en": "Comprehensive genetic analysis of gastrointestinal and hepatobiliary tumor",
    "type_study_ja": "NGS(WGS), NGS(Exome、RNA-seq), NGS(Exome、Target Capture、 RNA-seq)",
    "type_study_en": "NGS (WGS), NGS (Exome, RNA-seq), NGS (Exome, Target Capture, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0233",
    "hum_id": "hum0233",
    "label_ja": "小児肝癌に対する国際共同臨床試験（PHITT, JPLT4）付随研究",
    "label_en": "Paediatric Hepatic International Tumour Trial (JPLT4: PHITT)",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq) SNPアレイ メチル化アレイ NGS(WGBS)",
    "type_study_en": "NGS (Exome) NGS (RNA-seq) SNP array Methylation array NGS (WGBS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0286",
    "hum_id": "hum0286",
    "label_ja": "非アルコール性脂肪性肝疾患患者における肝癌発症・進展機序の解明",
    "label_en": "Elucidation of molecular mechanism of NAFLD-HCC",
    "type_study_ja": "NGS(Visium Spatial Gene Expression)、病理画像, NGS(Target Capture)",
    "type_study_en": "NGS (Visium Spatial Gene Expression), Histological image, NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0306",
    "hum_id": "hum0306",
    "label_ja": "国際連携によるがんゲノムシークエンス解析 （シークエンス解析によるがんゲノム研究）",
    "label_en": "Cancer Genome Sequencing Analysis",
    "type_study_ja": "NGS(WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0327",
    "hum_id": "hum0327",
    "label_ja": "個別化T細胞受容体遺伝子導入T細胞療法の臨床応用を目指した肝胆膵領域がんにおけるネオアンチゲンおよびそれを認識するT細胞受容体のスクリーニング",
    "label_en": "Screening of neoantigens and neoantigen reactive T cell receptors in hepatobiliary and pancreatic cancer for clinical application of personalized T cell therapy",
    "type_study_ja": "NGS(Exome、RNA-seq)",
    "type_study_en": "NGS (Exome, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200047",
    "nando_id": "NANDO:2200047",
    "hum_uri": "https://humandbs.dbcls.jp/hum0385",
    "hum_id": "hum0385",
    "label_ja": "混合型肝癌、細胆管細胞癌、Cytokeratin19陽性肝細胞癌、SOX9陽性肝細胞癌の網羅的DNA変異解析",
    "label_en": "Comprehensive genetic analysis of Combined hepatocellular-cholangiocarcinoma, Cholangiolocarcinoma, Keratin 19-expressing hepatocellular carcinoma, and SOX9-expressing hepatocellular carcinoma",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200048",
    "nando_id": "NANDO:2200048",
    "hum_uri": "https://humandbs.dbcls.jp/hum0270",
    "hum_id": "hum0270",
    "label_ja": "ゲノムおよび遺伝子解析に基づく骨軟部腫瘍に特異的な分子病理学的異常の解明と、新規診断および治療法の開発を目指したトランスレーショナル研究",
    "label_en": "Translational research for elucidating molecular and pathological abnormalities specific to bone and soft tissue tumors based on genomic and genetic analysis, and for developing new diagnostic and therapeutic strategies",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200050",
    "nando_id": "NANDO:2200050",
    "hum_uri": "https://humandbs.dbcls.jp/hum0401",
    "hum_id": "hum0401",
    "label_ja": "創薬をめざした新規骨・軟部肉腫細胞株および疾患モデル動物の開発",
    "label_en": "Development of cell lines and mouse models of bone and soft tissue sarcoma to establish novel treatment",
    "type_study_ja": "NGS(Exome、RNA-seq), NGS(RNA-seq)",
    "type_study_en": "NGS (Exome, RNA-seq), NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200052",
    "nando_id": "NANDO:2200052",
    "hum_uri": "https://humandbs.dbcls.jp/hum0401",
    "hum_id": "hum0401",
    "label_ja": "創薬をめざした新規骨・軟部肉腫細胞株および疾患モデル動物の開発",
    "label_en": "Development of cell lines and mouse models of bone and soft tissue sarcoma to establish novel treatment",
    "type_study_ja": "NGS(Exome、RNA-seq), NGS(RNA-seq)",
    "type_study_en": "NGS (Exome, RNA-seq), NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200056",
    "nando_id": "NANDO:2200056",
    "hum_uri": "https://humandbs.dbcls.jp/hum0035",
    "hum_id": "hum0035",
    "label_ja": "固形腫瘍における遺伝子異常の網羅的解析",
    "label_en": "Genome wide analysis of gene mutations in solid tumors",
    "type_study_ja": "RMSおよびPPBのNGS(Exome), PBLのSNP-chip PBLのメチル化アレイ PBLのNGS(Exome) PBLのNGS(RNA-seq), NBのSNP-chip NBのTarget amplicon deep sequencing(NGS), HBLのSNP-chip HBLのメチル化アレイ HBLのNGS(Target Capture) HBLのNGS(RNA-seq), 小児胚細胞腫瘍のSNP-chip 小児胚細胞腫瘍のメチル化アレイ 小児胚細胞腫瘍のNGS(Target Capture) 小児胚細胞腫瘍のNGS(RNA-seq), 小児高リスク神経芽腫のNGS(RNA-seq) 小児高リスク神経芽腫のNGS(Target Capture)",
    "type_study_en": "NGS (Exome) for RMS and PPB, SNP-chip for PBL Methylation array for PBL NGS (Exome) for PBL NGS (RNA-seq) for PBL, SNP-chip for NB Target amplicon deep sequencing (NGS) for NB, SNP-chip for HBL Methylation array for HBL NGS (Target Capture) for HBL NGS (RNA-seq) for HBL, SNP-chip for pediatric germ cell tumors Methylation array for pediatric germ cell tumors NGS (Target Capture) for pediatric germ cell tumors NGS (RNA-seq) for pediatric germ cell tumors, NGS (RNA-seq) for high-risk neuroblastoma NGS (Target Capture) for high-risk neuroblastoma",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200061",
    "nando_id": "NANDO:2200061",
    "hum_uri": "https://humandbs.dbcls.jp/hum0401",
    "hum_id": "hum0401",
    "label_ja": "創薬をめざした新規骨・軟部肉腫細胞株および疾患モデル動物の開発",
    "label_en": "Development of cell lines and mouse models of bone and soft tissue sarcoma to establish novel treatment",
    "type_study_ja": "NGS(Exome、RNA-seq), NGS(RNA-seq)",
    "type_study_en": "NGS (Exome, RNA-seq), NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200077",
    "nando_id": "NANDO:2200077",
    "hum_uri": "https://humandbs.dbcls.jp/hum0163",
    "hum_id": "hum0163",
    "label_ja": "精神・神経疾患治療薬及びがん治療薬におけるファーマコゲノミクス研究",
    "label_en": "Pharmacogenomics research for therapeutics in psychiatry, neurology and oncology",
    "type_study_ja": "NGS(Target Capture), NGS(NAT2ハプロタイプ同定), 水疱性類天疱瘡のGWAS",
    "type_study_en": "NGS (Target Capture), NGS (NAT2 haplotype), GWAS for bullous pemphigoid",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200077",
    "nando_id": "NANDO:2200077",
    "hum_uri": "https://humandbs.dbcls.jp/hum0216",
    "hum_id": "hum0216",
    "label_ja": "消化管癌を含む固形癌患者における免疫状態の解明と臨床的意義に関する研究 新規免疫療法や併用療法開発を目指した固形癌患者の免疫状態の解析",
    "label_en": "Analyses of immune status of patients with solid tumors including gastrointestinal cancer Investigation of anti-tumor immunological response in solid tumors",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200077",
    "nando_id": "NANDO:2200077",
    "hum_uri": "https://humandbs.dbcls.jp/hum0247",
    "hum_id": "hum0247",
    "label_ja": "がん患者免疫状態を反映するがん遺伝子変異の探索",
    "label_en": "Research for gene mutations in cancer representing immune status of the patients",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200077",
    "nando_id": "NANDO:2200077",
    "hum_uri": "https://humandbs.dbcls.jp/hum0272",
    "hum_id": "hum0272",
    "label_ja": "メラノーマ等、皮膚腫瘍病変の免疫状態の解析",
    "label_en": "Analysis of the immune status of melanoma and other skin tumors",
    "type_study_ja": "NGS(Exome) NGS(RNA-seq), NGS(Target Capture)",
    "type_study_en": "NGS (Exome) NGS (RNA-seq), NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200077",
    "nando_id": "NANDO:2200077",
    "hum_uri": "https://humandbs.dbcls.jp/hum0295",
    "hum_id": "hum0295",
    "label_ja": "皮膚腫瘍の診断と治療効果の評価および経過観察のためのバイオマーカーの探索（前向き観察研究）",
    "label_en": "Search for biomarkers for diagnosis, evaluation of therapeutic effect, and follow-up of skin tumors (prospective observational study)",
    "type_study_ja": "NGS(Amplicon-seq)",
    "type_study_en": "NGS (Amplicon-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200079",
    "nando_id": "NANDO:2200079",
    "hum_uri": "https://humandbs.dbcls.jp/hum0381",
    "hum_id": "hum0381",
    "label_ja": "切除不能または再発胸腺癌に対するニボルマブの多施設共同第II相試験（NCCH1505）附随研究",
    "label_en": "A biomarker study of a multicenter Phase II Trial of Nivolumab for Unresectable or Recurrent Thymic Carcinoma (NCCH1505)",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200080",
    "nando_id": "NANDO:2200080",
    "hum_uri": "https://humandbs.dbcls.jp/hum0035",
    "hum_id": "hum0035",
    "label_ja": "固形腫瘍における遺伝子異常の網羅的解析",
    "label_en": "Genome wide analysis of gene mutations in solid tumors",
    "type_study_ja": "RMSおよびPPBのNGS(Exome), PBLのSNP-chip PBLのメチル化アレイ PBLのNGS(Exome) PBLのNGS(RNA-seq), NBのSNP-chip NBのTarget amplicon deep sequencing(NGS), HBLのSNP-chip HBLのメチル化アレイ HBLのNGS(Target Capture) HBLのNGS(RNA-seq), 小児胚細胞腫瘍のSNP-chip 小児胚細胞腫瘍のメチル化アレイ 小児胚細胞腫瘍のNGS(Target Capture) 小児胚細胞腫瘍のNGS(RNA-seq), 小児高リスク神経芽腫のNGS(RNA-seq) 小児高リスク神経芽腫のNGS(Target Capture)",
    "type_study_en": "NGS (Exome) for RMS and PPB, SNP-chip for PBL Methylation array for PBL NGS (Exome) for PBL NGS (RNA-seq) for PBL, SNP-chip for NB Target amplicon deep sequencing (NGS) for NB, SNP-chip for HBL Methylation array for HBL NGS (Target Capture) for HBL NGS (RNA-seq) for HBL, SNP-chip for pediatric germ cell tumors Methylation array for pediatric germ cell tumors NGS (Target Capture) for pediatric germ cell tumors NGS (RNA-seq) for pediatric germ cell tumors, NGS (RNA-seq) for high-risk neuroblastoma NGS (Target Capture) for high-risk neuroblastoma",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200082",
    "nando_id": "NANDO:2200082",
    "hum_uri": "https://humandbs.dbcls.jp/hum0035",
    "hum_id": "hum0035",
    "label_ja": "固形腫瘍における遺伝子異常の網羅的解析",
    "label_en": "Genome wide analysis of gene mutations in solid tumors",
    "type_study_ja": "RMSおよびPPBのNGS(Exome), PBLのSNP-chip PBLのメチル化アレイ PBLのNGS(Exome) PBLのNGS(RNA-seq), NBのSNP-chip NBのTarget amplicon deep sequencing(NGS), HBLのSNP-chip HBLのメチル化アレイ HBLのNGS(Target Capture) HBLのNGS(RNA-seq), 小児胚細胞腫瘍のSNP-chip 小児胚細胞腫瘍のメチル化アレイ 小児胚細胞腫瘍のNGS(Target Capture) 小児胚細胞腫瘍のNGS(RNA-seq), 小児高リスク神経芽腫のNGS(RNA-seq) 小児高リスク神経芽腫のNGS(Target Capture)",
    "type_study_en": "NGS (Exome) for RMS and PPB, SNP-chip for PBL Methylation array for PBL NGS (Exome) for PBL NGS (RNA-seq) for PBL, SNP-chip for NB Target amplicon deep sequencing (NGS) for NB, SNP-chip for HBL Methylation array for HBL NGS (Target Capture) for HBL NGS (RNA-seq) for HBL, SNP-chip for pediatric germ cell tumors Methylation array for pediatric germ cell tumors NGS (Target Capture) for pediatric germ cell tumors NGS (RNA-seq) for pediatric germ cell tumors, NGS (RNA-seq) for high-risk neuroblastoma NGS (Target Capture) for high-risk neuroblastoma",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200087",
    "nando_id": "NANDO:2200087",
    "hum_uri": "https://humandbs.dbcls.jp/hum0088",
    "hum_id": "hum0088",
    "label_ja": "腫瘍細胞におけるTGF-βファミリーシグナルの網羅的解析",
    "label_en": "Global analysis of TGF-beta family signaling in cancer cells",
    "type_study_ja": "NGS(RNA-seq), NGS(WGS)",
    "type_study_en": "NGS (RNA-seq), NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200087",
    "nando_id": "NANDO:2200087",
    "hum_uri": "https://humandbs.dbcls.jp/hum0340",
    "hum_id": "hum0340",
    "label_ja": "小児固形腫瘍症例の次世代シークエンサーを用いた網羅的ゲノム解析",
    "label_en": "Comprehensive genomic analysis using next-generation sequencer for pediatric solid tumor cases",
    "type_study_ja": "NGS (WGS、Target Capture)",
    "type_study_en": "NGS(WGS, Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200089",
    "nando_id": "NANDO:2200089",
    "hum_uri": "https://humandbs.dbcls.jp/hum0006",
    "hum_id": "hum0006",
    "label_ja": "脳腫瘍のゲノム・遺伝子解析と その臨床病理学的意義の解明",
    "label_en": "Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance",
    "type_study_ja": "アストロサイトーマ NGS(Exome), グリオーマ(小脳・視床・大脳) NGS(Exome、RNA-seq)、Methylation array, グリオーマ NGS(Exome、RNA-seq)、Methylation array, グリオーマ(小脳・視床・大脳) NGS(Exome, RNA-seq), Methylation array, NGS(Target Capture), NGS(FLeCS-seq, SMART-seq, RNA-seq, short-read WGS, ultralong-read WGS)",
    "type_study_en": "astrocytoma NGS (Exome), gliomas (diffuse cerebellar glioma, cerebral glioblastoma, thalamic glioma) NGS (Exome, RNA-seq), Methylation array, gliomas NGS (Exome, RNA-seq), Methylation array, NGS (Target Capture), NGS(FLeCS-seq, SMART-seq, RNA-seq, short-read WGS, ultralong-read WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200091",
    "nando_id": "NANDO:2200091",
    "hum_uri": "https://humandbs.dbcls.jp/hum0456",
    "hum_id": "hum0456",
    "label_ja": "傍鞍部頭蓋底腫瘍及び、悪性神経膠腫組織を用いた分子生物学的解析による腫瘍の形成と機能的分化における分子病態の検討",
    "label_en": "Molecular Pathological exprolation of Tumor Formation and Functional Differentiation Using Parasellar Skull Base Tumors and Malignant Glioma Tissues",
    "type_study_ja": "NGS(scRNA-seq)",
    "type_study_en": "NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200121",
    "nando_id": "NANDO:2200121",
    "hum_uri": "https://humandbs.dbcls.jp/hum0476",
    "hum_id": "hum0476",
    "label_ja": "腎臓構成細胞の生物学的機能理解のための先端的解析技術を用いた観察研究",
    "label_en": "Observational studies using advanced analytical techniques to understand the biological functions of kidney component cells",
    "type_study_ja": "NGS(scRNA-seq) NGS(Visium Spatial Gene Expression)、病理画像",
    "type_study_en": "NGS (scRNA-seq) NGS (Visium Spatial Gene Expression), Histological image",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200201",
    "nando_id": "NANDO:2200201",
    "hum_uri": "https://humandbs.dbcls.jp/hum0406",
    "hum_id": "hum0406",
    "label_ja": "ヒト疾患特異的iPS細胞の作成とそれを用いた疾患解析に関する研究",
    "label_en": "The Generation of Human Disease-Specific iPS Cells and the Use of Such iPS Cells for Disease Analysis",
    "type_study_ja": "NGS(RNA-seq), NGS(scRNA-seq)",
    "type_study_en": "NGS (RNA-seq), NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200203",
    "nando_id": "NANDO:2200203",
    "hum_uri": "https://humandbs.dbcls.jp/hum0406",
    "hum_id": "hum0406",
    "label_ja": "ヒト疾患特異的iPS細胞の作成とそれを用いた疾患解析に関する研究",
    "label_en": "The Generation of Human Disease-Specific iPS Cells and the Use of Such iPS Cells for Disease Analysis",
    "type_study_ja": "NGS(RNA-seq), NGS(scRNA-seq)",
    "type_study_en": "NGS (RNA-seq), NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200226",
    "nando_id": "NANDO:2200226",
    "hum_uri": "https://humandbs.dbcls.jp/hum0014",
    "hum_id": "hum0014",
    "label_ja": "オーダーメイド医療の実現プログラム",
    "label_en": "Bio Bank Japan project",
    "type_study_ja": "162,255名の58臨床検査値のGWAS, 2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル(約20万例)から抽出された11,234名の23遺伝子における全てのエクソン領域のTarget Capture Sequencingn解析より得られた体細胞変異データおよびSNPアレイにより得られた染色体変異データ, 心筋梗塞1,765症例、認知症199症例のWGSデータ, 心筋梗塞1,666症例および 対照健常者3,198名のGWAS, 健常者934名の遺伝子型カウント情報 (JSNPのデータ), 食道がん182症例の遺伝子型カウント情報 (JSNPのデータ), 筋萎縮性側索硬化症92症例の遺伝子型カウント情報 (JSNPのデータ), ２型糖尿病9,817症例および 対照者6,763名のGWAS, ２型糖尿病5,646症例および 対照者19,420名のGWAS, アトピー性皮膚炎患者1,472症例および 対照者7,966名のGWAS, 心房細動患者8,180症例のPhenotypeデータ、Genotypeデータ, 心房細動患者8,180症例および対照者28,612名のGWAS, 158,284名のBMIのGWAS, 開放隅角緑内障3,980症例および 対照者18,815名のGWAS, 初潮年齢データを有する女性67,029名および閉経年齢データを有する女性43,861名のGWAS, ２型糖尿病腎症2,809症例および ２型糖尿病対照5,592症例のGWASメタ解析, ２型糖尿病36,614症例および 対照者155,150名のGWASメタ解析, 日本人集団165,436名における喫煙習慣のGWAS, 159,095名の身長のGWAS, 40疾患のGWAS, 日本人集団165,084名における食習慣のGWAS, 冠動脈疾患のGWAS, BBJ第1コホート137,693名の生存に関するGWAS, 心房細動患者9,826症例および対照者140,446名のGWAS(BBJ) 心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析(BBJ、欧米人、FinnGen), 乳がん7,104症例と対照者23,731名の遺伝性乳がん原因11遺伝子翻訳領域のTarget Capture Sequencingデータ, 遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のTarget Capture Sequencingデータ, 膵がん1,005症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, リンパ腫1,982症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 胃がん10,366症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingデータ, BBJ第1コホート4,880名のmobile element多型頻度情報, BBJ第1コホート1,007名のWGSデータ, 胃がん256症例のWGSデータ, BBJ第1コホートおよび第2コホート26.9万名のSNPアレイデータ, 大腸がん617症例のWGSデータ, 糖尿病2,162症例のWGSデータ(low-depth), 胃がん2,067症例のWGSデータ(low-depth), 35疾患各約190症例における遺伝子型カウント情報 (JSNPのデータ), バイオバンクジャパン7,472名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, バイオバンクジャパン3,256名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, 158,284名のBMIデータ 182,505名のGenotypeデータ, 乳がん10,008症例、胃がん10,576症例、大腸がん13,922症例および心不全6,038症例、脳梗塞10,486症例などを含む計140,597名を対象としたTP53のTarget Capture Sequencingデータ",
    "type_study_en": "GWAS for 58 quantitative traits, target sequencing of 23 genes related to clonal hematopoiesis and SNP array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007, WGS for 1,765 myocardial infarction patients and 199 dementia patients, GWAS for MI, Genotype frequencies in 934 healthy individuals (JSNP data), Genotype frequencies in 182 esophageal cancer patients (JSNP data), Genotype frequencies in 92 amyotrophic lateral sclerosis (ALS) patients (JSNP data), GWAS for T2DM [1], GWAS for T2DM [2], GWAS for AD, Genotype and phenotype data for 8180 AF patients, GWAS for AF, GWAS for BMI, GWAS for POAG, GWAS for age at menarche and menopause, meta analysis of 2 GWASs for T2DM with diabetic nephropathy, meta analysis of 4 GWASs for T2DM, GWAS for smoking behaviour, GWAS for height, GWAS for 40 diseases, GWAS for dietary habits, GWAS for coronary artery disease, GWAS for survival time in 137,693 individuals from BBJ 1st cohort, GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort GWAS meta-analysis for 77,690 AF patients and 1,167,040 controls, target sequencing of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls, target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls, target sequencing of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients, target sequencing of 27 cancer-predisposing genes in 12,503 colorectal cancer patients and 23,705 controls, target sequencing of 27 cancer-predisposing genes in 1,982 lymphoma patients, target sequencing of 27 cancer-predisposing genes in 10,366 gastric cancer patients, target sequencings of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls, mobile element variations in 4,880 individuals from BBJ 1st cohort, WGS for 1,007 individuals, WGS for 256 gastric cancer patients, SNP array for 269,000 patients (51 diseases) in BBJ 1st and 2nd cohort, WGS for 617 colorectal cancer patients, low-depth WGS for 2,162 diabetes patients, low-depth WGS for 2,067 gastric cancer patients, Genotype frequencies in each disease (JSNP data), Imputation reference panel for 7,472 Japanese WGS and 2,504 1000 Genome Project data, Imputation reference panel for 3,256 Japanese WGS and 2,504 1000 Genome Project data, BMI data for 158,284 individuals Genotype data for 182,505 individuals, target sequencings on the coding regions of TP53 in 140,597 individuals, including those with breast cancer, stomach cancer, colon cancer, heart failure, stroke, etc.",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200226",
    "nando_id": "NANDO:2200226",
    "hum_uri": "https://humandbs.dbcls.jp/hum0495",
    "hum_id": "hum0495",
    "label_ja": "心房細動と合併する脳梗塞予防のプレシジョン・メディシン",
    "label_en": "Precision medicine for preventing stroke in patients with atrial fibrillation",
    "type_study_ja": "発作性心房細動のExomeデータを元にしたGWAS統計情報, 発作性心房細動のGWAS統計情報",
    "type_study_en": "GWAS for PAF using whole exome sequencing data, GWAS for PAF",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200228",
    "nando_id": "NANDO:2200228",
    "hum_uri": "https://humandbs.dbcls.jp/hum0377",
    "hum_id": "hum0377",
    "label_ja": "不整脈症候群の遺伝子基盤に関する研究",
    "label_en": "Research on the genetic basis of arrhythmia syndrome",
    "type_study_ja": "NGS(Amplicon-seq)",
    "type_study_en": "NGS (Amplicon-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200229",
    "nando_id": "NANDO:2200229",
    "hum_uri": "https://humandbs.dbcls.jp/hum0404",
    "hum_id": "hum0404",
    "label_ja": "循環器疾患のゲノム解析技術、iPS細胞技術、ゲノム編集技術を用いた病態解明ならびに治療法開発研究 循環器疾患患者由来iPS細胞を用いた病態解明ならびに新規医療技術開発研究",
    "label_en": "Elucidation of pathology and therapeutic development using genome analysis, iPS cells, and genome editing for cardiovascular diseases Elucidation of pathology and development of novel medical technology using iPS cells derived from patients with cardiovascular disease",
    "type_study_ja": "NGS(scRNA-seq), NGS(WGS)",
    "type_study_en": "NGS (scRNA-seq), NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200230",
    "nando_id": "NANDO:2200230",
    "hum_uri": "https://humandbs.dbcls.jp/hum0404",
    "hum_id": "hum0404",
    "label_ja": "循環器疾患のゲノム解析技術、iPS細胞技術、ゲノム編集技術を用いた病態解明ならびに治療法開発研究 循環器疾患患者由来iPS細胞を用いた病態解明ならびに新規医療技術開発研究",
    "label_en": "Elucidation of pathology and therapeutic development using genome analysis, iPS cells, and genome editing for cardiovascular diseases Elucidation of pathology and development of novel medical technology using iPS cells derived from patients with cardiovascular disease",
    "type_study_ja": "NGS(scRNA-seq), NGS(WGS)",
    "type_study_en": "NGS (scRNA-seq), NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200248",
    "nando_id": "NANDO:2200248",
    "hum_uri": "https://humandbs.dbcls.jp/hum0014",
    "hum_id": "hum0014",
    "label_ja": "オーダーメイド医療の実現プログラム",
    "label_en": "Bio Bank Japan project",
    "type_study_ja": "162,255名の58臨床検査値のGWAS, 2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル(約20万例)から抽出された11,234名の23遺伝子における全てのエクソン領域のTarget Capture Sequencingn解析より得られた体細胞変異データおよびSNPアレイにより得られた染色体変異データ, 心筋梗塞1,765症例、認知症199症例のWGSデータ, 心筋梗塞1,666症例および 対照健常者3,198名のGWAS, 健常者934名の遺伝子型カウント情報 (JSNPのデータ), 食道がん182症例の遺伝子型カウント情報 (JSNPのデータ), 筋萎縮性側索硬化症92症例の遺伝子型カウント情報 (JSNPのデータ), ２型糖尿病9,817症例および 対照者6,763名のGWAS, ２型糖尿病5,646症例および 対照者19,420名のGWAS, アトピー性皮膚炎患者1,472症例および 対照者7,966名のGWAS, 心房細動患者8,180症例のPhenotypeデータ、Genotypeデータ, 心房細動患者8,180症例および対照者28,612名のGWAS, 158,284名のBMIのGWAS, 開放隅角緑内障3,980症例および 対照者18,815名のGWAS, 初潮年齢データを有する女性67,029名および閉経年齢データを有する女性43,861名のGWAS, ２型糖尿病腎症2,809症例および ２型糖尿病対照5,592症例のGWASメタ解析, ２型糖尿病36,614症例および 対照者155,150名のGWASメタ解析, 日本人集団165,436名における喫煙習慣のGWAS, 159,095名の身長のGWAS, 40疾患のGWAS, 日本人集団165,084名における食習慣のGWAS, 冠動脈疾患のGWAS, BBJ第1コホート137,693名の生存に関するGWAS, 心房細動患者9,826症例および対照者140,446名のGWAS(BBJ) 心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析(BBJ、欧米人、FinnGen), 乳がん7,104症例と対照者23,731名の遺伝性乳がん原因11遺伝子翻訳領域のTarget Capture Sequencingデータ, 遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のTarget Capture Sequencingデータ, 膵がん1,005症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, リンパ腫1,982症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 胃がん10,366症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingデータ, BBJ第1コホート4,880名のmobile element多型頻度情報, BBJ第1コホート1,007名のWGSデータ, 胃がん256症例のWGSデータ, BBJ第1コホートおよび第2コホート26.9万名のSNPアレイデータ, 大腸がん617症例のWGSデータ, 糖尿病2,162症例のWGSデータ(low-depth), 胃がん2,067症例のWGSデータ(low-depth), 35疾患各約190症例における遺伝子型カウント情報 (JSNPのデータ), バイオバンクジャパン7,472名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, バイオバンクジャパン3,256名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, 158,284名のBMIデータ 182,505名のGenotypeデータ, 乳がん10,008症例、胃がん10,576症例、大腸がん13,922症例および心不全6,038症例、脳梗塞10,486症例などを含む計140,597名を対象としたTP53のTarget Capture Sequencingデータ",
    "type_study_en": "GWAS for 58 quantitative traits, target sequencing of 23 genes related to clonal hematopoiesis and SNP array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007, WGS for 1,765 myocardial infarction patients and 199 dementia patients, GWAS for MI, Genotype frequencies in 934 healthy individuals (JSNP data), Genotype frequencies in 182 esophageal cancer patients (JSNP data), Genotype frequencies in 92 amyotrophic lateral sclerosis (ALS) patients (JSNP data), GWAS for T2DM [1], GWAS for T2DM [2], GWAS for AD, Genotype and phenotype data for 8180 AF patients, GWAS for AF, GWAS for BMI, GWAS for POAG, GWAS for age at menarche and menopause, meta analysis of 2 GWASs for T2DM with diabetic nephropathy, meta analysis of 4 GWASs for T2DM, GWAS for smoking behaviour, GWAS for height, GWAS for 40 diseases, GWAS for dietary habits, GWAS for coronary artery disease, GWAS for survival time in 137,693 individuals from BBJ 1st cohort, GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort GWAS meta-analysis for 77,690 AF patients and 1,167,040 controls, target sequencing of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls, target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls, target sequencing of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients, target sequencing of 27 cancer-predisposing genes in 12,503 colorectal cancer patients and 23,705 controls, target sequencing of 27 cancer-predisposing genes in 1,982 lymphoma patients, target sequencing of 27 cancer-predisposing genes in 10,366 gastric cancer patients, target sequencings of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls, mobile element variations in 4,880 individuals from BBJ 1st cohort, WGS for 1,007 individuals, WGS for 256 gastric cancer patients, SNP array for 269,000 patients (51 diseases) in BBJ 1st and 2nd cohort, WGS for 617 colorectal cancer patients, low-depth WGS for 2,162 diabetes patients, low-depth WGS for 2,067 gastric cancer patients, Genotype frequencies in each disease (JSNP data), Imputation reference panel for 7,472 Japanese WGS and 2,504 1000 Genome Project data, Imputation reference panel for 3,256 Japanese WGS and 2,504 1000 Genome Project data, BMI data for 158,284 individuals Genotype data for 182,505 individuals, target sequencings on the coding regions of TP53 in 140,597 individuals, including those with breast cancer, stomach cancer, colon cancer, heart failure, stroke, etc.",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200286",
    "nando_id": "NANDO:2200286",
    "hum_uri": "https://humandbs.dbcls.jp/hum0131",
    "hum_id": "hum0131",
    "label_ja": "発達障害のエピゲノム解析",
    "label_en": "The epigenetics of neurodevelopmental disorders",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200294",
    "nando_id": "NANDO:2200294",
    "hum_uri": "https://humandbs.dbcls.jp/hum0552",
    "hum_id": "hum0552",
    "label_ja": "クローン性造血と腹部大動脈瘤との関連を解明する研究",
    "label_en": "Study to elucidate the association between clonal hematopoiesis and abdominal aortic aneurysm",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200416",
    "nando_id": "NANDO:2200416",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200416",
    "nando_id": "NANDO:2200416",
    "hum_uri": "https://humandbs.dbcls.jp/hum0379",
    "hum_id": "hum0379",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(scRNA-seq、scVDJ-seq)",
    "type_study_en": "NGS (scRNA-seq, scVDJ-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200420",
    "nando_id": "NANDO:2200420",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200420",
    "nando_id": "NANDO:2200420",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200420",
    "nando_id": "NANDO:2200420",
    "hum_uri": "https://humandbs.dbcls.jp/hum0492",
    "hum_id": "hum0492",
    "label_ja": "産学連携による免疫炎症性難病の新規医薬品開発を目指した探索研究",
    "label_en": "Exploratory research aimed at developing new drugs for difficult-to-treat immune-inflammatory diseases through industry-academia collaboration",
    "type_study_ja": "NGS(scRNA-seq/TCR/BCRレパトア解析) NGS(Visium Spatial Gene Expression)、病理画像",
    "type_study_en": "NGS (scRNA-seq/TCR/BCR repertoire) NGS (Visium Spatial Gene Expression), Histological image",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200420",
    "nando_id": "NANDO:2200420",
    "hum_uri": "https://humandbs.dbcls.jp/hum0519",
    "hum_id": "hum0519",
    "label_ja": "自己免疫疾患の抗原特異性の詳細解析",
    "label_en": "Detailed analysis of antigen specificity in autoimmune diseases",
    "type_study_ja": "NGS(scRNA-seq/TCRレパトア解析)",
    "type_study_en": "NGS (scRNA-seq/TCR repertoire)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200422",
    "nando_id": "NANDO:2200422",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200422",
    "nando_id": "NANDO:2200422",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200423",
    "nando_id": "NANDO:2200423",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200426",
    "nando_id": "NANDO:2200426",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200429",
    "nando_id": "NANDO:2200429",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200429",
    "nando_id": "NANDO:2200429",
    "hum_uri": "https://humandbs.dbcls.jp/hum0218",
    "hum_id": "hum0218",
    "label_ja": "全身性強皮症患者の遺伝子発現解析",
    "label_en": "Gene expression analysis in systemic sclerosis",
    "type_study_ja": "NGS(scRNA-seq)",
    "type_study_en": "NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200429",
    "nando_id": "NANDO:2200429",
    "hum_uri": "https://humandbs.dbcls.jp/hum0416",
    "hum_id": "hum0416",
    "label_ja": "経時的な多層的オミックス解析を通した免疫難病及びがんにおける生体反応の解明と新規治療法の開発",
    "label_en": "Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis.",
    "type_study_ja": "NGS(BD Ab-seq), NGS(CITE-seq、BD Ab-seq), NGS(CITE-seq), シングルセル空間トランスクリプトーム, NGS(scRNA-seq)",
    "type_study_en": "NGS (BD Ab-seq), NGS (CITE-seq, BD Ab-seq), NGS (CITE-seq), single-cell spatial transcriptome, NGS (scRNA-seq)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200430",
    "nando_id": "NANDO:2200430",
    "hum_uri": "https://humandbs.dbcls.jp/hum0214",
    "hum_id": "hum0214",
    "label_ja": "ヒト免疫系の機能ゲノム学による統合的理解とこれを用いた免疫疾患の発症予防のためのインターベンション戦略の構築",
    "label_en": "Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases",
    "type_study_ja": "RNA-seqのリードカウント, Conditional eQTLサマリーデータ(有意データのみ), Nominal eQTLデータ(全データ), NGS(RNA-seq: 全身性強皮症), NGS(RNA-seq), NGS(RNA-seq)解析によるリードカウントデータ, RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ, NGS(scRNA-seq)解析によるカウントデータ, RNA-seqによるT細胞免疫細胞サブセットのT細胞受容体レパトアデータ",
    "type_study_en": "Read count data from RNA-seq, Conditional eQTL summary data (significant associations), Nominal eQTL data (including non-significant associations), NGS (RNA-seq: Systemic sclerosis), NGS (RNA-seq), B cell receptor repertoire clonotype data from B cell RNA-seq, NGS (scRNA-seq), T cell receptor repertoire clonotype data from T cell RNA-seq",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200460",
    "nando_id": "NANDO:2200460",
    "hum_uri": "https://humandbs.dbcls.jp/hum0137",
    "hum_id": "hum0137",
    "label_ja": "1型糖尿病関連遺伝子群の多施設共同研究",
    "label_en": "a multicenter study of susceptibility genes to type 1 diabetes",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200461",
    "nando_id": "NANDO:2200461",
    "hum_uri": "https://humandbs.dbcls.jp/hum0014",
    "hum_id": "hum0014",
    "label_ja": "オーダーメイド医療の実現プログラム",
    "label_en": "Bio Bank Japan project",
    "type_study_ja": "162,255名の58臨床検査値のGWAS, 2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル(約20万例)から抽出された11,234名の23遺伝子における全てのエクソン領域のTarget Capture Sequencingn解析より得られた体細胞変異データおよびSNPアレイにより得られた染色体変異データ, 心筋梗塞1,765症例、認知症199症例のWGSデータ, 心筋梗塞1,666症例および 対照健常者3,198名のGWAS, 健常者934名の遺伝子型カウント情報 (JSNPのデータ), 食道がん182症例の遺伝子型カウント情報 (JSNPのデータ), 筋萎縮性側索硬化症92症例の遺伝子型カウント情報 (JSNPのデータ), ２型糖尿病9,817症例および 対照者6,763名のGWAS, ２型糖尿病5,646症例および 対照者19,420名のGWAS, アトピー性皮膚炎患者1,472症例および 対照者7,966名のGWAS, 心房細動患者8,180症例のPhenotypeデータ、Genotypeデータ, 心房細動患者8,180症例および対照者28,612名のGWAS, 158,284名のBMIのGWAS, 開放隅角緑内障3,980症例および 対照者18,815名のGWAS, 初潮年齢データを有する女性67,029名および閉経年齢データを有する女性43,861名のGWAS, ２型糖尿病腎症2,809症例および ２型糖尿病対照5,592症例のGWASメタ解析, ２型糖尿病36,614症例および 対照者155,150名のGWASメタ解析, 日本人集団165,436名における喫煙習慣のGWAS, 159,095名の身長のGWAS, 40疾患のGWAS, 日本人集団165,084名における食習慣のGWAS, 冠動脈疾患のGWAS, BBJ第1コホート137,693名の生存に関するGWAS, 心房細動患者9,826症例および対照者140,446名のGWAS(BBJ) 心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析(BBJ、欧米人、FinnGen), 乳がん7,104症例と対照者23,731名の遺伝性乳がん原因11遺伝子翻訳領域のTarget Capture Sequencingデータ, 遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のTarget Capture Sequencingデータ, 膵がん1,005症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, リンパ腫1,982症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 胃がん10,366症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ, 腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingデータ, BBJ第1コホート4,880名のmobile element多型頻度情報, BBJ第1コホート1,007名のWGSデータ, 胃がん256症例のWGSデータ, BBJ第1コホートおよび第2コホート26.9万名のSNPアレイデータ, 大腸がん617症例のWGSデータ, 糖尿病2,162症例のWGSデータ(low-depth), 胃がん2,067症例のWGSデータ(low-depth), 35疾患各約190症例における遺伝子型カウント情報 (JSNPのデータ), バイオバンクジャパン7,472名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, バイオバンクジャパン3,256名のWGSデータと1000ゲノムプロジェクト(Phase3v5)2,504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel, 158,284名のBMIデータ 182,505名のGenotypeデータ, 乳がん10,008症例、胃がん10,576症例、大腸がん13,922症例および心不全6,038症例、脳梗塞10,486症例などを含む計140,597名を対象としたTP53のTarget Capture Sequencingデータ",
    "type_study_en": "GWAS for 58 quantitative traits, target sequencing of 23 genes related to clonal hematopoiesis and SNP array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007, WGS for 1,765 myocardial infarction patients and 199 dementia patients, GWAS for MI, Genotype frequencies in 934 healthy individuals (JSNP data), Genotype frequencies in 182 esophageal cancer patients (JSNP data), Genotype frequencies in 92 amyotrophic lateral sclerosis (ALS) patients (JSNP data), GWAS for T2DM [1], GWAS for T2DM [2], GWAS for AD, Genotype and phenotype data for 8180 AF patients, GWAS for AF, GWAS for BMI, GWAS for POAG, GWAS for age at menarche and menopause, meta analysis of 2 GWASs for T2DM with diabetic nephropathy, meta analysis of 4 GWASs for T2DM, GWAS for smoking behaviour, GWAS for height, GWAS for 40 diseases, GWAS for dietary habits, GWAS for coronary artery disease, GWAS for survival time in 137,693 individuals from BBJ 1st cohort, GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort GWAS meta-analysis for 77,690 AF patients and 1,167,040 controls, target sequencing of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls, target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls, target sequencing of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients, target sequencing of 27 cancer-predisposing genes in 12,503 colorectal cancer patients and 23,705 controls, target sequencing of 27 cancer-predisposing genes in 1,982 lymphoma patients, target sequencing of 27 cancer-predisposing genes in 10,366 gastric cancer patients, target sequencings of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls, mobile element variations in 4,880 individuals from BBJ 1st cohort, WGS for 1,007 individuals, WGS for 256 gastric cancer patients, SNP array for 269,000 patients (51 diseases) in BBJ 1st and 2nd cohort, WGS for 617 colorectal cancer patients, low-depth WGS for 2,162 diabetes patients, low-depth WGS for 2,067 gastric cancer patients, Genotype frequencies in each disease (JSNP data), Imputation reference panel for 7,472 Japanese WGS and 2,504 1000 Genome Project data, Imputation reference panel for 3,256 Japanese WGS and 2,504 1000 Genome Project data, BMI data for 158,284 individuals Genotype data for 182,505 individuals, target sequencings on the coding regions of TP53 in 140,597 individuals, including those with breast cancer, stomach cancer, colon cancer, heart failure, stroke, etc.",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200461",
    "nando_id": "NANDO:2200461",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200461",
    "nando_id": "NANDO:2200461",
    "hum_uri": "https://humandbs.dbcls.jp/hum0372",
    "hum_id": "hum0372",
    "label_ja": "多層的オミクス解析による疾患病態の解明 メタボリック・シンドローム関連疾患における個別化医療の実現",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "364代謝物の存在量, 364代謝物の要約統計量",
    "type_study_en": "the abundance of the 364 serum metabolites, the summary statistics",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200563",
    "nando_id": "NANDO:2200563",
    "hum_uri": "https://humandbs.dbcls.jp/hum0221",
    "hum_id": "hum0221",
    "label_ja": "ヒト疾患特異的iPS細胞を用いた遺伝子解析研究",
    "label_en": "Genetic study using human disease-specific iPS cells",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200579",
    "nando_id": "NANDO:2200579",
    "hum_uri": "https://humandbs.dbcls.jp/hum0302",
    "hum_id": "hum0302",
    "label_ja": "iPS細胞の高次特性解析と加工iPS細胞の作製",
    "label_en": "iPS Cell Advanced Characterization and Development of modified iPS cells",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200602",
    "nando_id": "NANDO:2200602",
    "hum_uri": "https://humandbs.dbcls.jp/hum0439",
    "hum_id": "hum0439",
    "label_ja": "脂質異常症に関わる遺伝子と病態との関連の検討",
    "label_en": "Investigation of the relationship between the genes involved in dyslipidemia and the pathogenesis of the disease",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200613",
    "nando_id": "NANDO:2200613",
    "hum_uri": "https://humandbs.dbcls.jp/hum0434",
    "hum_id": "hum0434",
    "label_ja": "T/NK細胞が関連する各種疾患における遺伝子解析",
    "label_en": "Genetic analyses in patients with T or NK cells-associated disorders",
    "type_study_ja": "NGS(Exome) NGS(Target Capture), NGS(Target Capture)",
    "type_study_en": "NGS (Exome) NGS (Target Capture), NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200618",
    "nando_id": "NANDO:2200618",
    "hum_uri": "https://humandbs.dbcls.jp/hum0378",
    "hum_id": "hum0378",
    "label_ja": "溶血性貧血の病態解明を目指した基礎研究",
    "label_en": "Basic research to elucidate the pathogenesis of hemolytic anemia",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200693",
    "nando_id": "NANDO:2200693",
    "hum_uri": "https://humandbs.dbcls.jp/hum0097",
    "hum_id": "hum0097",
    "label_ja": "骨髄不全症候群における血球の質に関する検討",
    "label_en": "Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200693",
    "nando_id": "NANDO:2200693",
    "hum_uri": "https://humandbs.dbcls.jp/hum0434",
    "hum_id": "hum0434",
    "label_ja": "T/NK細胞が関連する各種疾患における遺伝子解析",
    "label_en": "Genetic analyses in patients with T or NK cells-associated disorders",
    "type_study_ja": "NGS(Exome) NGS(Target Capture), NGS(Target Capture)",
    "type_study_en": "NGS (Exome) NGS (Target Capture), NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200708",
    "nando_id": "NANDO:2200708",
    "hum_uri": "https://humandbs.dbcls.jp/hum0368",
    "hum_id": "hum0368",
    "label_ja": "全ゲノム配列決定によるICF症候群の新規原因遺伝子の探索および機能解析",
    "label_en": "Identification and functional analysis of novel causative genes of ICF syndrome by whole genome sequencing",
    "type_study_ja": "NGS(PBAT-seq)",
    "type_study_en": "NGS (PBAT-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200826",
    "nando_id": "NANDO:2200826",
    "hum_uri": "https://humandbs.dbcls.jp/hum0375",
    "hum_id": "hum0375",
    "label_ja": "超高速DNAシーケンサーを用いた疾患原因ゲノム領域の同定と情報解析法の確立、および参照配列データの作成に関する研究",
    "label_en": "identification of disease responsible genome region and establishment of genome information technology by next generation DNA sequencer",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200828",
    "nando_id": "NANDO:2200828",
    "hum_uri": "https://humandbs.dbcls.jp/hum0107",
    "hum_id": "hum0107",
    "label_ja": "基底細胞母斑症候群患者からのinduced pluripotent stem （iPS）細胞の樹立および病態の解明、骨移植への臨床応用",
    "label_en": "Establish induced pluripotent stem (iPS) cells from patients with Gorlin syndrome and elucidate the pathology",
    "type_study_ja": "NGS(Exome), NGS(RNA-seq)",
    "type_study_en": "NGS (Exome), NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200828",
    "nando_id": "NANDO:2200828",
    "hum_uri": "https://humandbs.dbcls.jp/hum0276",
    "hum_id": "hum0276",
    "label_ja": "Gorlin症候群に対する汎用型遺伝子診断パネルの開発とリキッドバイオプシーへの応用",
    "label_en": "Development of a general-purpose genetic diagnostic panel for Gorlin syndrome and its application to liquid biopsy",
    "type_study_ja": "NGS(Target Capture)",
    "type_study_en": "NGS (Target Capture)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200829",
    "nando_id": "NANDO:2200829",
    "hum_uri": "https://humandbs.dbcls.jp/hum0277",
    "hum_id": "hum0277",
    "label_ja": "泌尿器科領域の腫瘍性疾患の発症、進展、及び薬剤の治療効果に関わる遺伝子の解析",
    "label_en": "Analysis of genes related to the oncogenesis, progression or effectiveness of drug therapies of urological tumors",
    "type_study_ja": "NGS(scRNA-seq、Exome、RNA-seq), NGS(WGS、RNA-seq)",
    "type_study_en": "NGS (scRNA-seq, Exome, RNA-seq), NGS (WGS, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200850",
    "nando_id": "NANDO:2200850",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200850",
    "nando_id": "NANDO:2200850",
    "hum_uri": "https://humandbs.dbcls.jp/hum0351",
    "hum_id": "hum0351",
    "label_ja": "画像検査と RNF213 遺伝子検査の融合による閉塞性血管障害の新評価体系の確立",
    "label_en": "New classification of occlusive cerebrovascular diseases by combining diagnostic imaging and genetic analysis of RNF213",
    "type_study_ja": "メタゲノム",
    "type_study_en": "Metagenome",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200864",
    "nando_id": "NANDO:2200864",
    "hum_uri": "https://humandbs.dbcls.jp/hum0404",
    "hum_id": "hum0404",
    "label_ja": "循環器疾患のゲノム解析技術、iPS細胞技術、ゲノム編集技術を用いた病態解明ならびに治療法開発研究 循環器疾患患者由来iPS細胞を用いた病態解明ならびに新規医療技術開発研究",
    "label_en": "Elucidation of pathology and therapeutic development using genome analysis, iPS cells, and genome editing for cardiovascular diseases Elucidation of pathology and development of novel medical technology using iPS cells derived from patients with cardiovascular disease",
    "type_study_ja": "NGS(scRNA-seq), NGS(WGS)",
    "type_study_en": "NGS (scRNA-seq), NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200864",
    "nando_id": "NANDO:2200864",
    "hum_uri": "https://humandbs.dbcls.jp/hum0514",
    "hum_id": "hum0514",
    "label_ja": "骨格筋メッセンジャーRNAの発現解析による神経・筋疾患の病態解明",
    "label_en": "Analysis of skeletal muscle messenger RNA expression to elucidate pathophysiology of neuromuscular diseases",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200901",
    "nando_id": "NANDO:2200901",
    "hum_uri": "https://humandbs.dbcls.jp/hum0347",
    "hum_id": "hum0347",
    "label_ja": "急性脳症の包括的遺伝子解析",
    "label_en": "Comprehensive genetic analysis of acute encephalopathy",
    "type_study_ja": "AESD症例のrs16944(IL1B)のgenotype, AESD症例のGWAS統計情報",
    "type_study_en": "rs16944 genotype of AESD patients, GWAS for AESD",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200904",
    "nando_id": "NANDO:2200904",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200904",
    "nando_id": "NANDO:2200904",
    "hum_uri": "https://humandbs.dbcls.jp/hum0379",
    "hum_id": "hum0379",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(scRNA-seq、scVDJ-seq)",
    "type_study_en": "NGS (scRNA-seq, scVDJ-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200906",
    "nando_id": "NANDO:2200906",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200906",
    "nando_id": "NANDO:2200906",
    "hum_uri": "https://humandbs.dbcls.jp/hum0321",
    "hum_id": "hum0321",
    "label_ja": "胸腺組織を介した免疫系構築の遺伝子制御に関する研究",
    "label_en": "Comprehensive analysis of interaction between human gene expression and environmental metagenomes",
    "type_study_ja": "NGS(scRNA-seq)",
    "type_study_en": "NGS (scRNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200906",
    "nando_id": "NANDO:2200906",
    "hum_uri": "https://humandbs.dbcls.jp/hum0379",
    "hum_id": "hum0379",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(scRNA-seq、scVDJ-seq)",
    "type_study_en": "NGS (scRNA-seq, scVDJ-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200920",
    "nando_id": "NANDO:2200920",
    "hum_uri": "https://humandbs.dbcls.jp/hum0166",
    "hum_id": "hum0166",
    "label_ja": "炎症性腸疾患患者におけるチオプリン関連副作用とNUDT15遺伝子多型との相関性に関する多施設共同研究（MENDEL Study）",
    "label_en": "Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study)",
    "type_study_ja": "炎症性腸疾患2680症例の個人毎のSNPアレイデータ, 炎症性腸疾患1221症例に対するチオプリン製剤による副作用(白血球減少症、脱毛症)の有無に関するGWAS",
    "type_study_en": "SNP array data of 2680 patients with inflammatory bowel diseases, GWAS for 1221 patients of inflammatory bowel diseases with thiopurine-induced adverse events (leukopenia, alopecia)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200920",
    "nando_id": "NANDO:2200920",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200920",
    "nando_id": "NANDO:2200920",
    "hum_uri": "https://humandbs.dbcls.jp/hum0454",
    "hum_id": "hum0454",
    "label_ja": "免疫異常に着目した炎症性腸疾患の病因解析および治療反応性解析",
    "label_en": "Etiological and therapeutic response analysis of inflammatory bowel disease focusing on immune abnormalities",
    "type_study_ja": "Xenium In Situ Gene Expression",
    "type_study_en": "Xenium In Situ Gene Expression",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200921",
    "nando_id": "NANDO:2200921",
    "hum_uri": "https://humandbs.dbcls.jp/hum0125",
    "hum_id": "hum0125",
    "label_ja": "制御性T細胞特異的エピゲノム誘導による免疫制御の研究",
    "label_en": "Immune regulation by cotrolling regulatory T cell-specific epigenome",
    "type_study_ja": "NGS(RNA-seq)",
    "type_study_en": "NGS (RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200921",
    "nando_id": "NANDO:2200921",
    "hum_uri": "https://humandbs.dbcls.jp/hum0166",
    "hum_id": "hum0166",
    "label_ja": "炎症性腸疾患患者におけるチオプリン関連副作用とNUDT15遺伝子多型との相関性に関する多施設共同研究（MENDEL Study）",
    "label_en": "Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study)",
    "type_study_ja": "炎症性腸疾患2680症例の個人毎のSNPアレイデータ, 炎症性腸疾患1221症例に対するチオプリン製剤による副作用(白血球減少症、脱毛症)の有無に関するGWAS",
    "type_study_en": "SNP array data of 2680 patients with inflammatory bowel diseases, GWAS for 1221 patients of inflammatory bowel diseases with thiopurine-induced adverse events (leukopenia, alopecia)",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200921",
    "nando_id": "NANDO:2200921",
    "hum_uri": "https://humandbs.dbcls.jp/hum0197",
    "hum_id": "hum0197",
    "label_ja": "多層的オミクス解析による疾患病態の解明",
    "label_en": "Elucidation of disease state by multi-layered omics analysis",
    "type_study_ja": "メタゲノム, 微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列, 視神経脊髄炎関連疾患のscRNA-seqの統合データ, 肺胞蛋白症のGWAS, 215形質のGWAS, 10形質のGWAS, 79形質のFine-mapping, miRNAリードカウント, eQTL解析データ, 頭蓋内胚細胞腫瘍のGWAS, 9形質のGWAS, scRNA-seqデータ, scRNA-seqデータ、臨床情報, scRNA-seqデータ、血漿プロテオームデータ, 15形質のGWAS, 間質性膀胱炎ハンナ型のGWAS, 腸内微生物叢のGWAS 血中代謝物のGWAS KEGG Gene OrthologおよびKEGG PathwayのGWAS, 2型糖尿病のGWASより算出した各バリアントの重みデータ, 不育症のGWAS, 自己免疫疾患のNGS (WGS) より算出した内在性ヘルペスウイルス6 (eHHV-6) の有無およびアネロウイルス量 scRNA-seqデータ, eHHV-6B陽性/陰性を示す自己免疫疾患のGWAS統計量, 縄文割合のGWAS, NGS (WGS、RNA-seq), 視神経脊髄炎関連疾患のGWAS統計量, eQTL統計量, 乾癬のGWAS統計量, 臨床形質およびメタボローム374形質に対するゲノムワイド遺伝子環境交互作用解析, Y染色体欠失のGWAS統計量, NGS (scRNA-seq、snMultiome), 重症筋無力症のGWAS統計量, もやもや病のGWAS統計量, 多発性硬化症のGWAS統計量, 多発性硬化症のscRNA-seqの統合データ",
    "type_study_en": "Metagenome, MAG, Viral genome and CRISPR spacers of Microbial genome, Integrated single-cell object data of PBMCs from 25 NMOSD patients, GWAS for autoimmune pulmonary alveolar proteinosis, GWAS for 215 phenotypes, GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes, Read count data of miRNA, eQTL data, GWAS for intracranial germ cell tumors, GWAS for 9 phenotypes, Raw sequencing data of single-cell RNA-seq, Raw sequencing data of single-cell RNA-seq, clinical data, scRNA-seq, plasma proteomics data, GWAS for 15 phenotypes, GWAS for Hunner-type interstitial cystitis, GWAS for gut microbiome GWAS for plasma metabolite GWAS for KEGG Gene Ortholog and KEGG Pathway, The weights of variants calculated from GWAS results on type 2 diabetes, GWAS for recurrent pregnancy loss, The presence or absence of endogenous herpesvirus 6 and anellovirus load calculated from NGS (WGS) for autoimmune diseases Raw sequencing data of single-cell RNA-seq, GWAS for autoimmune diseases, GWAS for the individual Jomon proportions, NGS (WGS, RNA-seq), Summary statistics of the genome-wide meta-analysis of NMOSD, Single-cell eQTL summary statistics of 40 immune cell types, GWAS for Psoriasis, Genome-wide gene-environment interaction studies for clinical traits and metabolites (374 phenotypes), GWAS for loss of the Y chromosome, NGS (scRNA-seq, snMultiome), GWAS for myasthenia gravis, GWAS for Moyamoya disease, GWAS for multiple sclerosis, Integrated single-cell object data of PBMCs from 20 MS patients",
    "type_data_ja": "Controlled-access (Type I), Unrestricted-access",
    "type_data_en": "Controlled-access (Type I), Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200921",
    "nando_id": "NANDO:2200921",
    "hum_uri": "https://humandbs.dbcls.jp/hum0454",
    "hum_id": "hum0454",
    "label_ja": "免疫異常に着目した炎症性腸疾患の病因解析および治療反応性解析",
    "label_en": "Etiological and therapeutic response analysis of inflammatory bowel disease focusing on immune abnormalities",
    "type_study_ja": "Xenium In Situ Gene Expression",
    "type_study_en": "Xenium In Situ Gene Expression",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200930",
    "nando_id": "NANDO:2200930",
    "hum_uri": "https://humandbs.dbcls.jp/hum0486",
    "hum_id": "hum0486",
    "label_ja": "胆道閉鎖症およびアラジール症候群特異的iPS細胞を用いた胆管発生およびその障害メカニズムの解明",
    "label_en": "Bile duct development and its failure mechanisms using biliary atresia and Alagille syndrome-specific iPS cells",
    "type_study_ja": "NGS(WGS)",
    "type_study_en": "NGS (WGS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200937",
    "nando_id": "NANDO:2200937",
    "hum_uri": "https://humandbs.dbcls.jp/hum0138",
    "hum_id": "hum0138",
    "label_ja": "固形腫瘍における遺伝子異常の網羅的解析",
    "label_en": "Clonal structure and oncogenic potential of liver cirrhosis tissues",
    "type_study_ja": "NGS(Exome、RNA-seq)",
    "type_study_en": "NGS (Exome, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200937",
    "nando_id": "NANDO:2200937",
    "hum_uri": "https://humandbs.dbcls.jp/hum0195",
    "hum_id": "hum0195",
    "label_ja": "消化器癌における遺伝子異常についての網羅的解析",
    "label_en": "Comprehensive genetic analysis of gastrointestinal and hepatobiliary tumor",
    "type_study_ja": "NGS(WGS), NGS(Exome、RNA-seq), NGS(Exome、Target Capture、 RNA-seq)",
    "type_study_en": "NGS (WGS), NGS (Exome, RNA-seq), NGS (Exome, Target Capture, RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200945",
    "nando_id": "NANDO:2200945",
    "hum_uri": "https://humandbs.dbcls.jp/hum0008",
    "hum_id": "hum0008",
    "label_ja": "ヒルシュスプルング病および ヒルシュスプルング類縁疾患の 遺伝要因および発症機構解明に関する研究",
    "label_en": "Research for genetic causes and mechanisms of Hirschsprung's",
    "type_study_ja": "NGS (Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2200972",
    "nando_id": "NANDO:2200972",
    "hum_uri": "https://humandbs.dbcls.jp/hum0129",
    "hum_id": "hum0129",
    "label_ja": "神経疾患患者からのiPS細胞の樹立とそれを用いた疾患解析に関する研究",
    "label_en": "Research for analyzing mechanistic insight into disease progression of neural disease based on iPS cell technology",
    "type_study_ja": "NGS(ChIP-seq)",
    "type_study_en": "NGS (ChIP-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2201003",
    "nando_id": "NANDO:2201003",
    "hum_uri": "https://humandbs.dbcls.jp/hum0271",
    "hum_id": "hum0271",
    "label_ja": "ハプロ不全により発症する常染色体優性遺伝性疾患における表現型発現の個体差に関する包括的ゲノム解析研究",
    "label_en": "Comprehensive genome analysis related to individual differences in phenotypic expression in autosomal dominant diseases caused by haploinsufficiency",
    "type_study_ja": "NGS(Target Capture、Target RNA-seq)",
    "type_study_en": "NGS (Target Capture, Target RNA-seq)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2201006",
    "nando_id": "NANDO:2201006",
    "hum_uri": "https://humandbs.dbcls.jp/hum0029",
    "hum_id": "hum0029",
    "label_ja": "Stevens-Johnson症候群に対する 遺伝子多型解析",
    "label_en": "Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome",
    "type_study_ja": "SJSのGWAS, SJS/TENのGWAS",
    "type_study_en": "GWAS for SJS, GWAS for SJS/TEN",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2201007",
    "nando_id": "NANDO:2201007",
    "hum_uri": "https://humandbs.dbcls.jp/hum0029",
    "hum_id": "hum0029",
    "label_ja": "Stevens-Johnson症候群に対する 遺伝子多型解析",
    "label_en": "Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome",
    "type_study_ja": "SJSのGWAS, SJS/TENのGWAS",
    "type_study_en": "GWAS for SJS, GWAS for SJS/TEN",
    "type_data_ja": "Unrestricted-access",
    "type_data_en": "Unrestricted-access"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2201276",
    "nando_id": "NANDO:2201276",
    "hum_uri": "https://humandbs.dbcls.jp/hum0097",
    "hum_id": "hum0097",
    "label_ja": "骨髄不全症候群における血球の質に関する検討",
    "label_en": "Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome",
    "type_study_ja": "NGS(Exome)",
    "type_study_en": "NGS (Exome)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  },
  {
    "nando_uri": "http://nanbyodata.jp/ontology/NANDO_2201322",
    "nando_id": "NANDO:2201322",
    "hum_uri": "https://humandbs.dbcls.jp/hum0324",
    "hum_id": "hum0324",
    "label_ja": "脳血管障害及び神経筋難病の遺伝子解析研究",
    "label_en": "Genetic analysis of cerebrovascular diseases and neuromuscular disorders",
    "type_study_ja": "NGS(WGBS)",
    "type_study_en": "NGS (WGBS)",
    "type_data_ja": "Controlled-access (Type I)",
    "type_data_en": "Controlled-access (Type I)"
  }
]